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Abstract
The detection of clinically relevant disease-specific biomolecules, including nucleic acids,
circulating tumor cells, proteins, antibodies, and extracellular vesicles, has been indispensable
to understand their functions in disease diagnosis and prognosis. Therefore, a biosensor for the
robust, ultrasensitive, and selective detection of these low-abundant biomolecules in body
fluids (blood, urine, and saliva) is emerging in current clinical research. In recent years,
nanomaterials, especially superparamagnetic nanomaterials, have played essential roles in
biosensing due to their intrinsic magnetic, electrochemical, and optical properties. However,
engineered multicomponent magnetic nanoparticle-based current biosensors that have
excellent stability in a complex biomatrix; easy and alterable biorecognition of ligands,
antibodies, and receptor molecules; and unified point-of-care integration have yet to be
achieved. This review introduces the recent advances in superparamagnetic nanostructures for
electrochemical and optical biosensing for disease-specific biomarkers. This review
emphasizes the synthesis, biofunctionalization, and intrinsic properties of nanomaterials
essential for robust, ultrasensitive biosensing. With particular emphasis on nanostructure-based
electrochemical and optical detection of disease-specific biomarkers such as nucleic acids
(DNA and RNA), proteins, autoantibodies, and cells, this review also chronicles the needs and
challenges of nanoarchitecture-based detection. These summaries provide further insights for
researchers to inspire their future work in the development of nanostructures for integrating
into biosensing and devices for a broad field of applications of analytical sensing and clinics.
Keywords: Disease-specific biomolecules, biomarker, superparamagnetic, nanostructure,
biofunctionalization, signal amplification, nanozymes, electrochemical and optical detection,
biosensors
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1. Introduction
Detection of a disease-specific biomolecular target, including DNA- and RNA-based
biomarkers, circulating tumor cells, and small molecules (exosomes), is essential to understand
its physiological and biological functions, disease diagnosis, and prognosis.1-5 These
biomolecules carry out several anatomical and physiological functions: for instance, DNA
encodes genetic information for the development and regulation of genetic expression; RNA
transmits that genetic information and translates it into proteins for structural and regulatory
roles and therefore is involved in protein expression and different cellular functions.6-8
Exosomes, membrane-bound cargo that is enriched with proteins, lipid rafts, micro RNAs
(miRNAs), messenger RNAs (mRNAs), and other noncoding RNAs (ncRNAs), exchange
genetic information between neighboring cells during their circulation.9 Moreover, they are
now routinely used for the diagnosis and management of many diseases as the disease
progresses, resulting in alternation of the physiological state or genetic expression of these
biomolecules. Consequently, there has been a rising demand for detection of those
biomolecules, especially for early diagnosis and treatment. Early-stage detection enables
effective therapies to reduce suffering and disease-related burdens. Over the last century,
numerous detection platforms have been developed to detect these biomolecules. These
methodologies range from classical molecular biology to advanced procedures, such as
bisulfite sequencing,10 microarrays,11 quantitative real-time PCR (qRT-PCR),12 RNA
sequencing,13 colorimetry,14 surface plasmon resonance (SPR),15 and surface-enhanced Raman
spectroscopy (SERS),16 to more recent analytical approaches such as high-performance liquid
chromatography (HPLC),17 mass spectrophotometry (MS),18 and electrochemical biosensors.6,
4
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The classical molecular biology techniques, despite of their robustness and high efficiency,

nevertheless suffer from sensitivity and specificity (amplification biases) and require
cumbersome sample pretreatment and expensive instrumentation.20-22 HPLC and MS can
provide rapid, accurate, and selective detection, but they are limited in practical application
due to their high cost, bulky equipment size, immobility, specialized operation, and throughput.
Notably, they are not suitable when an ultrasensitive, miniaturized, portable detection system
is looked for in field and wearable applications.23, 24 Optical and electrochemical methodologies
are relatively inexpensive and rapid, and they provide sensitive detection in a portable
arrangement with a small volume input of clinical samples.6, 19, 25 Furthermore, tremendous
advances in microfabrication and allied technologies have been have been improving the
design and development of electrical readout-based chemical sensors and biosensors.26
However, target-specific electrode surface modification is vital to achieve the selectivity of a
functional biosensor. The most straightforward and widely used approach is to immobilize
enzymes or proteins (antibodies) on the electrode with a polymer layer.27 Additionally, the
sensor needs to bind with signaling or redox molecules to produce the target-specific responses.
Even though a plethora of cutting-edge electrochemical biosensors have been developed, most
of the approaches still suffer from low sensitivity, complex instrumentation, and multifaceted,
tedious, and time-consuming chemistry. Furthermore, the clinical application of most of these
has yet to be realized.
With the advancement of nanotechnology, nanostructured magnetic materials have
aroused immense interest in the field of analytical sensing and biomedicine due to their flexible
and modular structure, easy synthesis, small size, low toxicity, intrinsic enzyme-mimicking
activity, superparamagnetic behavior, and biocompatibility.28-30 With their small volume,
magnetic NPs (MNPs) smaller than the single domain limit (~20 nm for iron oxide) reveal
superparamagnetism at room temperature; i.e., MNPs (ferromagnetic) lose their magnetism
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below their Curie temperature.30-32 In brief, the magnetic moment of an individual NP able to
rotate randomly (in reference to the orientation of the MNP) by the influence of temperature.
Due to the fact that, in the absence of an electromagnetic field, the net magnetic moment of
NPs became zero at high enough temperatures. However, in the presence of a magnetic field,
a net statistical alignment of magnetic moments occurs, similar to that of paramagnetic
materials. This characteristic, obvious by the lack of remnant magnetization (i.e., the value of
the magnetization at zero field) after elimination of external magnetic fields. This enables
MNPs to maintain their colloidal stability and avoid agglomeration, which is essential for
magnetic manipulation of the sample in order to achieve nonspecific response free, highly
specific and sensitive detection of target molecules.33 MNPs uniquely combine with more
modestly sized or same-size molecular analytes and hence are often involved in isolation,
purification, target-molecule-carrying, signal-generating, and signal-enhancing steps in
biosensing, resulting in specific and highly sensitive diagnosis in clinics (Fig. 1).34-36
Nanostructured materials also exhibit impressive advantages in molecular diagnostics,
particularly in disease diagnosis applications. For instance, they break down the barrier to
structural miniaturization of diagnostic platforms, enable direct contact with sensing
environments (e.g., electrolyte, labeler), and provide reagentless biosensing, biomimetic, in
vivo detection, allowing them to be used as carrier or capture vehicles for loading a large
number of specific biological probes.37-39 In addition, the plasmonic and electrochemical
properties of nanostructured materials can be exploited to adopt many novel transduction
schemes, and the nanozyme activity could potentially replace natural enzymes in a wide range
of uses in ELISA-like biosensing.36, 40 Over the past few decades, numerous superparamagnetic
NPs have been synthesized, including iron oxides (Fe3O4 and Fe2O3); different ferrites of
cobalt, nickel, and manganese; gold-containing ferric oxide; graphene; and other functional
nanostructured wrapped iron oxides.41-43 In recent years, porous nanomaterials have also
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attracted increasing interest, as they possess a large surface area and large pore volumes,
narrow pore-size distribution, high loading capacity, and modifiable surface characteristics.42,
44, 45

These intrinsic properties enabled them highly potential for the uptake and release of guest

molecules. The porous structure has also improved catalytic volume as they increase the mass
transfer as compared to that of bulk materials of the same mass.46, 47] Notably, for detecting
biomarkers, each nanostructure is designed in such a way that it is biocompatible with the target
(cells, proteins, exosomes, DNA, RNA, etc.) and can be integrated into target-isolation and
purification, immobilization, signal-transduction, signal-generating, or signal-amplification
steps. Thus, nanostructures need to be highly specific and selective of the biomolecule structure
(shape, size, length, charge, interaction affinity, etc.).
Based on the synthesis, intrinsic characteristics, and application of nanostructure
materials, several reviews have also been authored in which their different synthetic strategies,
functionalization, and biosensing were discussed.34, 43, 48-52 There is extensive literature based
on the promise, facts, and challenges of the various nanostructures, e.g., graphene,53 carbon
nanotubes,54 and quantum dots55 in biomedical applications, and the human healthcare field
has already been expressly focusing on individual materials and their uses in biosensing.
Recently, we authored “Nanoarchitecture Frameworks for Electrochemical miRNA
Detection,”56 in which the pros and cons of previously reported nanostructures were discussed
with regard to microRNA detection. Another review also explored the structure-based
relationship for sensing performance; however, no specific biomolecules were considered.57
No reviews have yet focused on the nanostructures that are specifically engineered for the
detection of disease-specific biomarkers. Reports are needed in which the target-specific and
unique engineering of nanostructures is comprehensively discussed to guide future science in
detecting biomarkers, and hence disease diagnosis and prognosis. In summary, a review that
focuses

on

biomolecule-specific

magnetic
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nanostructure

synthesis,

further

biofunctionalization, and intrinsic properties is required to achieve robust biosensing and
magnetic nanostructure-based electrochemical and optical biosensors (nucleic acid sensor,
immunosensor, cytosensor, etc.).
In this review, we have focused extensively on the biomolecule-specific magnetic
nanostructure synthesis, further biofunctionalization, and intrinsic properties required to
achieve robust biosensing and magnetic nanostructure-based, clinically relevant disease
biomarker

detection.

Following

the

particular

emphasis

on

nanostructure-based

electrochemical and optical detection, the nanostructure-based point-of-care diagnostics are
also discussed. With a comprehensive discussion in each section, this review also chronicles
the needs and challenges involved in nanoarchitecture-based biomarker detection.
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Fig. 1 Schematic representation of the building blocks of nanoengineered superparamagnetic
nanoparticles, their surface functionalization, and their functions for integration into
biomolecular biosensors.

2. Synthesis of superparamagnetic nanoparticles
To date, various approaches have been developed for the synthesis of superparamagnetic NPs
and porous nanomaterials with controlled narrow size distribution for desired chemical and
physical properties. Among the types of superparamagnetic NPs, ferrite colloids, magnetite,
and maghemite are widely studied due to their biodegradability and biocompatibility. Broadly,
the synthetic methodology can be categorized into three classes: general synthesis of MNPs,
such as coprecipitation, thermal decomposition, microemulsion, hydrothermal reaction, and
sol–gel synthesis; templating methods for the synthesis of porous nanomaterials; and doped
metal synthesis for biofavorable hybrid metal NPs.
2.1. General synthesis
The conventional and most commonly used wet chemical methods for the synthesis of
superparamagnetic iron oxide nanoparticles (IONPs) are the coprecipitation method, wherein
Fe3O4 and γ-Fe2O3 are precipitated from a basic solution of ferric and ferrous salts or by
oxidation of a ferrous hydroxide suspension using oxidizing agents.58, 59 A mixture of ferric
and ferrous ions in a 1:2 molar ratio is used to obtain iron oxide precipitation at room
temperature or elevated temperature according to the following reaction;
.
The size and shape of the IONPs depend on the type of iron salt (e.g., chloride, sulfide,
or nitrite), ferric and ferrous ion ratio, pH of the solution, reaction temperature, and reaction
conditions. One of the most pioneering examples of this method was reported by Sugimoto
(1980): iron oxides were obtained by the interaction of FeSO4 with KOH in the presence of a
9

nitrate ion followed by aging of the resultant gelatinous suspension at 90 °C for several hours.60
Since then, several coprecipitation-based methods have been developed to synthesize IONPs.
For example, Fe3O4 magnetic powder with an average gain diameter of 15 nm was prepared
from high-purity iron using ultrasonic-assisted chemical coprecipitation.61 Recently, Pereira et
al. reported a one-step aqueous coprecipitation-based method for the synthesis of MFe2O4 using
the alkanolamines isopropanolamine and di-iso-propanolamine as an alkaline agent.62 The
synthesized MFe2O4 nanomaterials exhibited high colloidal stability, particle sizes in the range
of 4−12 nm, and superparamagnetic properties. Moreover, this method generated smaller
particle sizes (up to 6 times) and superior saturation magnetization (up to 1.3 times) than those
prepared with NaOH or KOH. This method can be used to prepare IONPs on a large scale in a
short time. NPs of different sizes and morphologies were also obtained by adjusting the pH,
oxidizing agents, ionic strength, and concentration of the growth solution. Moreover, the
stirring rate and reaction time have a considerable effect on the structural properties,
specifically the particle sizes and corresponding magnetic properties.63 However, the
coprecipitation method is limited by the fact that the produced NPs tend to agglomerate in
aqueous and physiological conditions. To overcome this limitation, different polymers,
polyethylene or surfactants such as dextran and polyvinylalcohol (PVA), are used to
immobilize the IONPs.64, 65
The thermal decomposition approach can be used to obtain highly crystalline,
monodisperse, and narrowly size-distributed IONPs from the high-temperature thermal
decomposition of coordinated iron precursors or organometallics such as Fe (cup)3 (cup = Nnitrosophenylhydroxylamine), Fe(acac)3 (acetylacetonate), or Fe(CO)5 in organic solvents.66
In this method, precursors are injected into either a hot reaction mixture (high temperature) or
a room temperature reaction mixture, followed by heating in a closed or open reaction vessel.
A size-controlled monodispersed IONPs synthesis was reported by Sun and Zeng, wherein
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Fe(acac)3 in phenyl ether was heated to 265 °C in the presence of alcohol, oleic acid, and
oleylamine. Larger monodispersed NPs with a size of up to 20 nm were obtained by using
smaller MNP seeds.67 This procedure does not need a size selection process. The size of the
IONPs is controlled by varying the aging temperature and other reaction parameters. This
method is suitable for preparing NPs with a different shape (nanospheres or nanocubes). The
size and shape can also be tailored by using varieties of precursors, solvents, or additives during
the thermal decomposition process. One of the shortcomings of this approach is that the exact
shape of the IONPs is not reproducible, as the nucleation of NPs involves boiling the solvents.
The nanomaterial produced via this method is usually dissolved in nonpolar solvents.
An alternative wet chemical method for obtaining crystalline NPs is the hydrothermal
one, wherein a mixture of iron salts was dissolved in an aqueous medium and heated in a sealed
Teflon container at a temperature (130 to 250 °C) higher than the boiling point of water and
high vapor pressure (0.3 to 4 MPa).68, 69 This method generates higher crystalline MNPs with
a superior magnetic feature due to the synergistic effect of high temperature and pressure. The
microemulsion method is also employed for the synthesis of shape- and size-controlled MNPs.
The binary system (water/surfactants or oil/surfactants) of microemulsion, which can be
formed by different types of self-assembled structures such as spherical and cylindrical
micelles, enables the desired growth, nucleation, and agglomeration of NPs.70 In this method,
an iron-containing nanoemulsion is mixed with sodium hydroxide, followed by lysis with
acetone to remove the surfactants. The dynamics of MNPs and controlled size can be achieved
by varying the droplet size, reactant concentrations, and surfactant nature. Although these
colloidal NPs show higher superparamagnetic properties, they need several washing
procedures to remove surfactants and further stabilization before use in biomedical
applications. Another two-phase method for the synthesis of NPs is the sol–gel method,
wherein the hydroxylation and condensation of precursor molecules in solution generate the
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sol of nanometric particles. A three-dimensional metal oxide wet gel is obtained by further
condensation and inorganic polymerization. Heat treatments are also required to obtain a
crystalline state, as gel preparation is carried out at room temperature. The predetermined
nanostructure with a pure amorphous phase and monodisperse, size-controlled NPs can be
synthesized using the sol–gel method.71 For instance, γ-Fe2O3 in silica with a size of 15 to 30
nm was synthesized by heating the gel to 400 °C. The gel was prepared by the hydrolysis of
Fe(NO3)3·9H2O and tetraethyl orthosilicate (TEOS) in ethanol.72 Some physical methods have
also been developed to synthesize MNPs, such as electron beam lithography and gas-phase
deposition.73 These methods required tedious and time-consuming procedures and were unable
to generate size-controlled NPs. In comparison to physical processes, the wet chemical
methods are more straightforward, more tractable, and more efficient for the synthesis of
monodisperse, highly crystalline, superparamagnetic NPs with controlled size, shape, and
composition.74
2.2. Template-based synthesis
The term “template synthesis” represents the direct preparation of nanomaterials with a
uniform morphology, such as size and shape, using a central structure as a template.69, 75 Within
the template, a network structure is formed in such a manner that removal of the template may
create a cavity with the designed morphological and stereochemical nanostructure. The
template enables higher reproducibility of the structure and provides a skeleton for obtaining
the desired function of a nanostructure.76 Template synthesis generally involves three main
steps: first, selection or creation of the template; second, assembly or synthesis of the desired
nanomaterials using common synthetic strategies; and third, removal of the template to
generate a porous nanostructure. Broadly, there are three template-based syntheses: (i) softtemplating methods, (ii) hard-templating methods, and (iii) sacrificial-templating methods. The
soft-templating methods use structurally flexible materials such as surfactants, polymers,
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micelles, and viruses, whereas in hard templating, the porous materials were prepared using a
rigid structure such as colloidal silica, latex, or a carbon sphere.77 Elimination of the template
is relatively simple and easy in soft templating. Hard templating is advantageous for the
synthesis of stable, controlled morphological NPs, but it requires tedious template removal
procedures. Thus, proper template selection is a prerequisite for obtaining the desired porous
nanostructure.
Soft-templating approaches have been used for the synthesis of a variety of hollow
nano- and microstructures, including superparamagnetic metal oxides78 and metals (e.g., Ni,
Pd, and Ag).79-81 An emulsion, micelle, vesicle, or hydrophilic polymer is generally employed
as a template. These soft templates are usually aggregated via inter- and intramolecular
interactions such as hydrogen bonding, Van der Waals forces, and chemical bonding.82 The
inorganic precursor is then deposited onto the surface of the interior of the template following
conventional precipitation, electrochemical, or other synthetic approaches. Finally, removal of
the soft template is usually carried out via a more straightforward process, such as washing or
evaporation. This method offers excellent repeatability and a simpler operation and avoids
chemical or structural changes during template removal. As the biological system requires mild
template removal, this technique has the potential for the synthesis of a hollow structure with
biosensitive functionalities such as molecular catalysis, biocatalysis, and biosensing.
Moreover, using an emulsion template, hollow shells with an additional functional component
such as bioactive or catalytically active species can be synthesized by incorporating them into
the hollow materials.83 For example, Lu et al. reported achieving a magnetic Fe3O4@hC/noble-metal rattle-type NP by incorporating surface-functionalized, preexisting Fe3O4
nanocrystals into the droplets of oil/water emulsion, followed by interfacial polymerization to
generate a hollow polymer shell Fe3O4@h-P.84 The shell contains a carboxylate group and
binds the noble metal via an ion exchange process. The metal cation was then converted to
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nanocrystals via pyrolysis under an inert atmosphere. Soft templates are sensitive to reaction
parameters such as pH, temperature, and solvent polarity, which presents challenges to using
this method to obtain a hollow structure with a particular structural feature.
In hard-template synthesis, a rigid material provides the size, morphology, and surface
properties of nanostructured materials. Colloidal SiO2, latex, and carbon spheres are the most
frequently used materials as a hard template. In addition to the three steps of the soft-templating
method, hard templating adopts one more step. The hard template inhibits the aggregation or
crystallization of the precursor molecules and allows the generation of NPs with a structure
opposite to that of the template. The surface of the as-synthesized template materials needs to
be either modified or functionalized to fit its chemical compatibility with the precursor
molecules. Different synthetic approaches to forming the shell on the template have been
applied to prepare the desired hollow nanostructure. The shells are formed by adsorption, layerby-layer methods, chemical deposition, or nanocasting.69 In the adsorption methods, precursor
molecules are adsorbed on the surface of the template materials via electrostatic attraction
followed by thermal treatment to induce cross-linking and development of the continuous shell.
For example, Wang et al. demonstrated the synthesis of three nanoporous metal oxides (Fe2O3
nanorods, NiO nanosheets, and Co3O4 NPs) using sulfonated polystyrene (SP) microspheres as
a hard template.85 The SP microsphere was achieved by gradual sulfonation of the outer sphere
of polystyrene. When the sulfonated SP microsphere was placed in the solution of precursor
metal salt, the ions from the precursor adsorbed within the outer surface of the sphere. A further
heat treatment simultaneously cross-linked the metal precursors into the shell and removed the
template polymer particles, thereby generating the hollow (hierarchical) metal oxide. Layerby-layer methods also involve the electrostatic adsorption of metal precursor ions around the
template materials to form alternating layers of oppositely charged building blocks.86 Unlike
the adsorption or layer-by-layer shell formation, the chemical deposition method utilizes the
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chemical attachment of the shell precursors to the template surface. Here, cross-linking of the
precursor occurs via condensation or polymerization reactions and does not require further heat
treatment to develop a continuous shell around the template materials.87 Nanocasting synthesis
offers superior structural features of hollow materials, such as shell thickness, porosity, and
higher mass-transport properties.88 In the above discussed methods, a porous scaffold around
the shell is initially formed, followed by the infiltration of precursors into the porous rim of the
template materials. Thermal or chemical treatment is required for appropriate cross-linking.
The synthesis of nonspherical hollow materials using a hard template remains challenging due
to the lack of templates and difficulties in achieving uniform surface (sharp edge and corners)
coverage on template.89
Another template-based method, called a sacrificial template, is used to synthesize
various magnetic metal oxide NPs. The use of metal–organic frameworks (MOFs) or porous
coordination polymers (PCPs) as a sacrificial template has drawn significant attention due to
their structural diversity, large surface area, and different surface morphologies.90 Though
thermal decomposition or calcination of iron oxide or iron hydroxide at a certain temperature
generated porous NPs, the pore volumes and pore size obtained by this method are not very
large. However, thermal treatment of MOFs or PCPs produces microporous metal/metal oxide
NPs with a large surface area. Prussian blue (PB) coordination polymers and PB analogues are
considered the most promising cyano-bridged MOFs for preparing porous metal oxide NPs. In
such MOFs, iron ions are bridged by cyano groups [(-Fe-CN-Fe)-]. Cyano groups are labile
and easily removed (C and N are oxidized into gases and escape) by calcination, resulting in
porosity in the metal nanostructure with super/quasisuperparamagnetism. 91 Recently, some
attempts to synthesize porous iron oxide through the thermal decomposition of PB have been
reported. For instance, Hu et al. synthesized elongated PB nanocubes via selective etching
followed by the conversion of PB crystals into a mixture of iron (III) oxide.91, 92 However, the
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obtained NPs had a low surface area, poor crystallinity, and several crystalline phases (α, ,
and γ phases). To overcome such limitations, Yamauchi et al. synthesized nanoporous IOs
(crystalline α-Fe2O3 and γ-Fe2O3) with hollow interiors by calcinating previously prepared
hollow PB nanocubes.91 The crystalline phases and their crystalline grain sizes were controlled
by the volume of internal hollow cavities in PB nanocubes and by the calcination temperature
(Fig. 2). The cubic structure was preserved even at a higher calcination temperature (400 °C).
Moreover, the crystalline phase of porous nanocubes became higher at an elevated temperature,
but the particle size slightly decreased with increasing temperature. The reduction in particle
size arises from the higher degree of decomposition of cyano groups. In addition to this method,
later on, Yamauchi et al. controlled the particle size (from 20 nm to 500 nm) of nanoporous
metal oxides by adjusting the amount of sodium citrate chelating agent for the synthesis of
hollow PB nanocubes.93
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Fig. 2 Schematic illustration of the fate of PB nanoparticles at different applied calcination
temperatures. Reproduced with permission.91

2.3. Multicomponent (hybrid) magnetic nanoparticle synthesis
Hybrid nanomaterials combining two or more functional constituents and nanoscale
functionalities have attracted increasing interest due to their numerous applications in
electronics, catalysis, bioimaging, biotechnology, and nanotechnology.94 In hybrid (bimetallic)
materials, one metal may confer the electrochemical or optical or both properties, whereas
others may provide long-term stability, biocompatibility, and specific affinity to target
biomolecules. During synthesis, the individual component may be combined and optimized
independently for target analysis. Hybrid materials achieve the cooperative performance of
individuals via interaction between or among constituents. To date, most biomolecular analyses
involving hybrid materials have been reported with the combination of MNPs (mainly iron
oxide) with gold (Au). However, other metals such as Pt, Zn, and Cu have also been explored.
In addition to these, the synthesis of carbon and graphene, silica-containing hybrid materials,
has been reported as a promising platform for biomedical applications. The general strategy for
obtaining composite NPs is to prepare one NP, followed by coating or loading another
constituent (metal or nonmetal) or using the first NP as a nucleation seed to deposit other
materials.94, 95
Au-containing MNPs (mostly iron oxide based) (Au@MNPs) have attracted particular
interest in the electroanalytical chemistry for bioseparation, the fabrication of immunoassays,
and the development of optical and electrochemical sensors due to the superparamagnetic
properties of magnetic materials and the biofavorable (i.e., optical and electrical) behavior of
Au.96,

97

Different synthetic approaches have been reported for monodispersed Au-FexOy

nanohybrids with diverse morphologies such as core/satellite, core/shell, multilayer, Au-coated
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iron oxide, and flower-like structures (Fig. 3).98 In recent last decades, a significant number of
Au-FexOy nanocomposites have been reported for the development of different biosensing tools
such as glucose sensors and aptasensors.99 For instance, Chin et al. (2009) synthesized
monodispersed Au and silver (Ag)–coated superparamagnetic Fe3O4 core-shell NPs via seedmediated growth. A thin layer of 2–3 nm Au NPs and Ag were attached to –NH2 functionalized
superparamagnetic Fe3O4 through the reduction of Au3+ and Ag+.100 Very recently, we
developed an electrocatalytically active gold-loaded nanoporous superparamagnetic nanocube
(Au@NPFe2O3NC) in which 2% Au NPs were loaded onto the porous cubic Fe2O3 nanocubes
via the reduction of HAuCl4. A porous Fe2O3 nanocube was prepared by the calcination of
Prussian blue (PB) nanocubes followed by the thermal decomposition of that porous PB
powder.45

Fig. 3 Schematic representation of the conversions of selected multilayer FexOy@Au
composites. Reproduced with permission.98

Carbon nanomaterials such as graphene, graphene oxide (GO), and carbon nanotubes (CNTs)
have also played a significant role in biomolecular analysis. For example, two-dimensional
graphene (or GO) possesses excellent surface-bound properties such as a large surface area (up
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to 2630 m2/g), unique sp2/sp3 bonded structure, thermal conductivity, and high carrier mobility.
They (carbon NMs) demonstrate a different binding affinity toward the double-stranded and
single-stranded DNA and thereby are used in designing a sensor to detect DNA or a DNAbased marker by discriminating between different DNA sequences. Inspiring form their
intrinsic

properties,

several

graphene-containing

superparamagnetic

iron

oxide

nanocomposites have been synthesized. A one-step synthesis of Fe3O4 NPs decorated with
reduced graphene oxide was reported by Teymourian et al. for the sensing of various analytes
(e.g., NADH, H2O2, uric acid, nitrite, ascorbic acid, and dopamine).101 A bifunctional Fe3O4Pt/rGO has also been reported, wherein Fe3O4 and Pt NPs were coated onto the rGO surface.102
This nanocomposite had been used for the catalytic reduction of methylene blue and the aerobic
oxidation of benzyl alcohol. Very recently, a new composite of GO sheets and PB consisting
of a different ratio of GO and PB has been reported by Tanaka et al.103 They synthesized
nanoporous GO/iron oxide (IO) hybrid composites via thermal decomposition of GOsheets/PB composites in the air at 400 °C. Among all ratios (GO:PB ratio = 25:75, 50:50, and
75:25), the 25:75 ratio resulted in a higher surface area (120 m2 g1) than those of the pure GO
(34.9 m2 g1) and IO (93.1 m2 g1) samples. In addition to GO, a number of multiwalled CNTcontaining IO nanohybrids also possessed promising applications for catalysis and biosensing
due to their combined functionalities, such as the high chemical stability and electrical
conductivity of cylindrical graphene sheets and the superparamagnetic properties of IO.54, 104

3. Surface functionalization of superparamagnetic nanoparticles
The ability to tune the surface in a controllable manner and at a particular molecular level
makes possible the use of MNPs in biomedical and biotechnological applications. Generally,
MNPs have a large surface-to-volume ratio (10–50 m2g-1) and thus possess surface energy. In
order to minimize the surface energy, naked IONPs tend to aggregate via magnetic interactions,
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limiting their dispersion in solution and complex matrices.105, 106 Moreover, naked IONPs have
high chemical activity and are easily oxidized in the air; they are unstable in strong acidic
solutions and undergo leaching, which actively reduces their magnetism, reusability, and
lifetime. Therefore, surface functionalization or covering of the surface with biocompatible
compounds is crucial to (i) prevent degradation in an aqueous, acidic, or aggressive (blood)
environment; (ii) suppress the magnetic interactions to avoid aggregation; and (iii) provide a
functional group to bind or attach a wide range of biomolecules (e.g., protein and nucleic acids).
These strategies include coating with biofavorable inorganic materials; immobilization with
small organic molecules, surfactants, polymers, or biomolecules; and functionalization with
metal and inorganic substances such as silica, graphene, gold, or platinum.
3.1. Small organic molecules, functional groups, and surfactants
Organic molecule–functionalized superparamagnetic NPs have been used in various
applications, especially in the field of biomedicine for targeted drug delivery, magnetic cell
separation and isolation, designing immunoassays, etc.66 To prevent particle aggregation and
preserve good biocompatibility, IONPs are generally functionalized using different organic
materials (e.g., polyethylene glycol (PEG), dextran, and starch) and various functional groups
such as –OH, -COOH, -NH2, and –SH.106 These functionalized groups are also suitable for the
further addition of different bioactive molecules for targeted bioapplication. For example,
small-sized silane is used to modify the end groups of the IONP surfaces for conjugating NPs
with

polymer

or

other

metal

ions,

biomolecules,

or

biological

entities.107

p-

Aminophenyltrimethoxysilane (APTS), mercaptopropyltriethoxysilane (MPTES) and 3aminopropyltriethoxysilane (APTES) agents are the most commonly used silanes for fastening
the -NH2 and –SH groups. For instance, Shen et al. reported a synthetic approach of APTScoated magnetic IONPs (Fe3O4@APTS), where Fe3O4 NPs (mean diameter 6.5 nm) were
synthesized in the presence of APTS via the hydrothermal synthetic route to obtain an amine
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functional group on the IO surfaces.108 The organic compounds oleic acid and oleylamine,
which consist of a C18 tail with a cis-double bond, play essential roles in the adequate
stabilization of IONPs via high-temperature thermal decomposition, as they can form a stable,
protective monolayer around the synthesized IO.59 For instance, oleic acid (OA) has been used
to coat Fe3O4 during the synthesis via thermal decomposition of Fe(acac)3. The resulting OAcoated NPs had an OA coating 3 nm thick and possessed good superparamagnetic properties
(magnetic saturation value 78.68 emu/g).109
Moreover, the IONPs obtained from the organic iron precursor are capped with
nonpolar groups, and they become stable in organic solvents such as hexane. These
hydrophobic NPs generally are not suitable for biological applications. In order to make them
biocompatible, the hydrophobic organic phase needs to be replaced or transferred by the
aqueous phase. To prepare water-soluble MNPs directly, small molecules such as amino acids,
cyclodextrin, or citric acid need to be used in the reaction process.110, 111 For example, Gao et
al. synthesized hydrophilic superparamagnetic colloidal nanocrystals using an anionic
polyelectrolyte PSSMA (4-styrenesulfonic acid-co-maleic acid) sodium salt containing both
sulfonate and carboxylate groups as the stabilizer. The synthesis was achieved by a one-step
solvothermal method. The nanocrystals were well dispersed in an aqueous solvent such as
water, PBS buffer, or ethanol.112 In addition to these approaches, ligand-exchange
transformation is used to convert oil-soluble functionalized iron oxide NPs to a water-soluble
ones. This method involves the addition of an excess amount of hydrophilic ligands into the
nanoparticle solution, resulting in displacement of the original ligands on the NP surface. A
ligand-exchange method was reported for the synthesis of monodispersed water-soluble MNPs
where oleic groups present (initially) on the NP surfaces were replaced by various capping
agents bearing reactive hydroxyl moieties via ligand-exchange reactions.113 These hydroxyl
groups could be exploited to initiate ring-opening polymerization of polylactic acid from the
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nanoparticle surfaces and esterified by acylation to permit the addition of alkyl halide moieties
(Fig. 4). Various surfactants, such as dodecyl amine, sodium oleate, and sodiumcarboxymethyl cellulose, were also used to enhance the dispersibility of MNPs in aqueous
media.114

Fig. 4 Schematic representation of the functionalization of magnetic nanoparticles. Steps 1A
and 1B: ligand-exchange reactions. Step 2: acylation of hydroxyl groups to prepare ATRP
surface initiators. Step 3A: surface-initiated ring-opening polymerization of L-lactide. Step 3B:
surface-initiated ATRP. Step 4: deprotection or additional reaction after polymerization. Step
5: grafting of end-functionalized PEG chains onto the nanoparticle surface using amidation
chemistry. Reproduced with permission.113
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3.2. Polymers
Polymer-functionalized MNPs have drawn much attention due to several advantages of
polymer coating, such as that polymer coating increases the pharmacokinetics and
biodistribution of NPs and increases the Van der Waals attractive and repulsive forces to
balance the magnetic forces on the NPs.59, 106 Several natural and biodegradable synthetic
polymers, such as polysaccharides, polyaspartate, polyethylene glycol (PEG), poly(vinyl
alcohol), and poly(vinyl-pyrrolidone), are currently used to produce MNPs with tailored and
desired properties.59, 66, 68 There are two main purposes for the polymer coating of NPs: one is
to broaden the application of NPs by introducing different functional groups, and the other is
to manufacture monodisperse NPs with a controlled composition and well-defined shape.
However, after polymerization, the superparamagnetic properties of NPs have been decreased.
The conventional approaches to the polymer functionalization of MNPs are in-situ and
postsynthesis coating. In the in-situ strategy, the NPs can be functionalized with polymers
through mini- or microemulsion polymerization or the sol–gel process during the synthesis of
NPs.115 Here, the organic precursor molecules capped the IONPs and formed an overlying layer
through emulsion polymerization. The conventional structure obtained by this approach is
mainly a matrix-dispersed structure or a core–shell structure.116 Unfortunately, this method
failed to maintain the colloidal stability and thickness of the shell. The predominant method of
polymer coating is postsynthesis functionalization, where the polymer functionalization has
been carried out on the prepared IONPs via the one-pot method, self-assembly, or
heterogeneous polymerizations. The resulting polymer@NPs is prone to form core–shell
structure. In addition, a number of heterogeneous polymerizations with different water-soluble
monomers have been used to prepare a well-defined monodisperse core–shell structure.117 An
example of such polymerization was reported by Pimpha et al., where an all-in-one NP
platform was developed using an oil-in-water emulsion system. The emulsion consisted of an
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iron oxide nanocrystal containing a hydrophobic oil core. The oil droplets were successively
stabilized by a lipid mixture containing a near-infrared (NIR) fluorophore (Cy5.5), followed
by further modification with PEGylated lipids to increase the stability of the particles. The lipid
mixture favors the creation of small particles of 30–100 nm.118 Currently, MNPs are modified
with smart polymers, which provide stimulus-responsive characteristics such as pH,
temperature, and light for a wide variety of biomedical applications such as drug delivery, MRI,
biomimetics, and biosensors.119-121
3.3. Bioactive molecules
In recent years, biomolecule-functionalized MNPs have drawn attention in nanomedicine due
to their biocompatibility and diverse application in the separation of biomolecules from
complex biomatrix, detection, sensor-development, and other bioapplications. Numerous small
biomolecules such as proteins, antibodies, enzymes, human/bovine serum albumin, avidin, and
peptides have bound onto the surface of NPs.122-125 The bioactive molecules can be attached to
the surface of NPs, mostly by activating the functional groups. In this strategy, small particles
or polymer-functionalized NPs are synthesized, followed by the addition of biomolecules
through physical adsorption or chemical bond. For example, Lee et al. reported an approach to
conjugating the IONPs with single-strand oligonucleotides. In this report, water-soluble
carboxyl group–containing magnetic γ-Fe2O3 was prepared, followed by modification of the
NP surface with streptavidin. Streptavidin-functionalized γ-Fe2O3 NPs were then used to bind
biotin-labeled oligonucleotides via the strong affinity interactions between avidin
(streptavidin) and biotin.126 The reactivity of the NP surface–linked carboxyl group can be
modified by the reaction with thionyl chloride (SOCl2) followed by coupling with the hydroxyl
group–containing small molecules.127 As this approach has been carried out under anhydrous
conditions (e.g., in DMSO or in the presence of AlCl3), it is not suitable for immobilizing
antibodies or enzymes. EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) and NHS (N-
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hydroxysuccinimide) can be used instead of anhydrous reagents to make the carboxylated NPs
suitable for amine group or enzyme immobilizations.128 In this modification, the aggregation
of NPs via cross-linking of the particles also happened; therefore, it is not ideal for
immobilizing proteins. Proteins can be immobilized on the surface of NPs with thiol functional
groups. The protein–thiol bonds are highly selective, and thiol groups reduce the probability of
NP aggregation.129 Another way to achieve chemical modification of NPs with proteins,
antibodies, or enzymes is via the attachment of bifunctional aldehyde groups (e.g.,
glutaraldehyde) to their premodified amine groups through the Schiff-base condensation
reactions.130
3.4. Inorganic materials
Inorganic materials can possess numerous outstanding properties, such as high electron density
and strong optical properties (e.g., Au and Ag), photoluminescence (e.g., CdSe, CdTe, and
Y2O3), magnetic moment (e.g., cobalt and manganese oxides), and affinity interaction with
biomolecules (e.g., Au, GO, and Pt).30,

131-135

Inorganic metal functionalization greatly

enhances the antioxidation properties of unmodified NPs (e.g., iron oxides). Moreover, this
coating extends the optoelectronic, storage, biocompatibility, catalytic, and sensing properties,
and thereby, inorganic material–functionalized magnetic materials become very promising for
application in catalysis, bioseparation, biolabeling, biosensing (optical and electrochemical),
and so on. Different inorganic materials such as silica, Au, carbon, GO, and metal oxides have
been used to functionalize NPs, especially IONPs in nanomedicine.
Silica-coated MNPs such as IONPs (IONP@SiO2) are promising and widely used
nanocomposite materials for biological applications. They possess several advantages: (i) silica
coating enhances the dispersion of NPs in solution and complex biological samples, as silica
coating can screen the interparticle interactions; (ii) they have good biocompatibility, stability,
and hydrophilicity; (iii) the variation of silica shell thickness is relatively easy and
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straightforward; and (iv) silica coating enables the binding of biomolecules of other
biofavorable ligands for biological applications.136 In general, three strategies have been used
to prepare IONP@SiO2 nanocomposites: the Stöber process, microemulsion synthesis, and
aerosol pyrolysis. The Stöber process is the commonly used method for silica coating. In this
method, IONPs are dispersed in alcohols, followed by the addition of silane. Water or ammonia
solution is then added to form IONP@SiO2. The thickness of silica can easily be tuned from 5
to 200 nm by varying the concentration of ammonia and the ratio of silica precursors
(tetraethoxysilane, TEOS).137 For example, Xuan et al. synthesized a monodisperse
Fe2O3@mesoSiO2 as a bifunctional agent for application in drug carriers and MRI.138 Micelles
or inverse micelles have been used in the microemulsion process to obtain a confined and
controlled coating of silica on core IONPs.139 This process requires the additional separation
of core–shell NPs from a large number of surfactants. In aerosol pyrolysis, IONP@SiO2 is
obtained by phase segregation of the iron precursors (bulk iron) and silica oxide or alkoxides
in flame environments.140
Carbon-coated NPs (e.g., IONP@C) have also attracted enormous interest in
bioapplications due to their elevated intrinsic electrical conductivity and excellent chemical
and thermal stability. Carbon protects the NPs from oxidation and corrosion of the core
materials. In general, a carbon coating can be applied using a simple three-step process. MNPs
are first prepared using conventional synthetic approaches. MNPs generally act as seeds. Then
the selective polymer is coated via a polymerization process. Finally, the IONP@C composite
is generated by the annealing treatments.66 Recently, much attention has been drawn to the
functionalization of magnetic materials by using highly conductive GOs. IONP/GO hybrid
materials have been used in biological fields; for example, Chen et al. synthesized an aminodextran coated-Fe3O4/GO composite for cellular MRI.141
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Different metallic NPs (e.g., Au, Ag, Pt, Cu, and Co) possess different properties, such
as optical (surface plasmon resonance, light scattering, surface-enhanced Raman scattering),
electrical (conductivity), and catalytic ones, and are widely used in contrast imaging, catalysis,
sensing, and medicine.142,

143

The combination of such metals with MNPs significantly

enhances the functional properties of metal/NP composite via cooperative interaction of the
intrinsic properties of metal and metal oxide NPs. Among all metal-coated NPs, Au-coated
IONPs have been intensively studied and showed enormous potential in biotechnology and
biomedicine.143 More specifically, the planar gold surfaces or gold nanoparticles (AuNPs) hold
significant advantages for the electrochemical and optical detection of biomolecules, as they
have a selective and specific affinity toward DNA, RNA, antibodies, and proteins.133 However,
the Au coating on MNPs is not thick enough and may cause aggregation. Hence, ionic capping
ligands must be attached to the system during NP synthesis. Moreover, Au-coated MNPs
(Au@MNPs) can be modified with a variety of molecular linkers to bind the target analyte for
designing optical and electrochemical biosensors. For example, MNP@Au can be adjusted
with 1,9-nonanedithiol and mercaptoundecanoic acid (MUA) through the ligand-exchange
reactivity at the gold shells to form a thin film assembled core (iron oxide)–shell (gold)
nanocomposite. The assembly of Fe3O4@Au nanoparticles involved an initial thiolate–
oleylamine exchange reaction followed by cross-linking. The cross-linking was carried out by
using the alkyl chain (dithiol as linker A) or hydrogen bonding (carboxylic acid–functionalized
thiol as linker B) as shown in Fig. 5.144
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Fig. 5 Schematic representation of the thiolate–oleylamine exchange reaction followed by
cross-linking via different linkers (A and B) for the assembly of Fe3O4@Au NPs. Fe3O4 core:
dark circle; Au shell: gray circle; oleylamine monolayer: thin gray zigzag lines. Reproduced
with permission.144

Various metal oxides and metal sulfides, such as ZnO, TiO2, Al2O3, CuO, CdS, ZnS,
and PbS, have also been used to modify the surface of MNPs for a wide variety of biological
technologies, as they add unique and selective properties to nanocomposites.145-148 For
example, Li et al. prepared air-stable Fe3O4@Al2O3 core–shell NPs through displacement
reactions. The NPs possessed high magnetic responses and were used to capture a MALDI
target.149 In another example, thiol-modified superparamagnetic γ-Fe2O3 beads were modified
by CdSe@ZnS quantum dot NPs to form luminescent/magnetic nanocomposite particles via
thiol–metal conjugations. The composites showed a threefold higher emission quantum yield,
and their emission peaks showed a slight blue shift as compared with individual luminescent
QDs. This luminescent/magnetic nanocomposite was used for cell separation, magnetic
separation, and luminescent detection.150

4. The function of superparamagnetic nanoparticles in biosensor development
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Superparamagnetic materials are traditionally used for the concentration, magnetic separation,
isolation and purification, and identification of molecules and cells. Recently, the magnetic
properties of superparamagnetic particles have also been used as detection and signalamplifying tools in various biosensing platforms. The electrocatalytic activity is largely utilized
to enhance detection sensitivity and specificity. Superparamagnetic materials are also used as
nanocarriers to transfer different biomolecules or bring target biomolecules to a biosensing
system. Additionally, it has been discovered that several superparamagnetic NPs, especially
magnetic ferric oxide–containing NPs, exhibited intrinsic natural enzyme-like activity.
4.1. Magnetic capture and separations
Superparamagnetic nanomaterials are becoming a promising tool for the capture,
concentration, isolation, and separation of biomolecules such as in vitro cells, antibodies,
proteins, DNA, enzymes, bacteria, and different pathogens from their complex biological
matrixes.29,

66, 151

MNPs offer several significant advantages over conventional separation

techniques such as chromatography: they possess a large surface-to-volume ratio, are readily
dispersible in solution, can be quickly localized or retrieved using a typical external magnet,
and provide high versatility and reusability of NPs after the magnetic separation.152 Generally,
MNPs are functionalized with different surfactants, polymers, and ligands to introduce
functional end groups such as –OH, -NH2, -COOH, and –SH for the selective capturing of
target biomolecules. The porous structure of polymer beads containing a magnetic core is also
employed to capture size-induced biomolecules. The separation of target biomolecules can be
achieved via hydrophobic interactions, antibody–antigen interactions, or direct affinity
adsorptions. Two factors greatly influence the separation efficiency of NPs: (i) the amount of
active functional group per mass of magnetic materials and (ii) the saturation magnetization
value.153 A large amount of functional group and high saturation magnetisation value favours
the efficient separation of biomolecules. Magnetic microsphere or composite materials fulfill
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these two requirements, as they contain a higher amount of magnetic materials, a porous
polymer structure, and selective metal structure for affinity interaction with target
biomolecules. NPs with a porous structure can also be good candidates, as they have an
enormous surface area and the ability to incorporate a larger number of functional groups or
adsorbed manifold biomolecules. A schematic representation of the magnetic separation of
biomolecules is shown in Fig. 6.

Fig. 6 Schematic representation of superparamagnetic NP–based bioseparation of
biomolecules. Reproduced with permission.154
Recently, Min et al. isolated and purified genomic DNA from human blood using
monodisperse biofunctionalized superparamagnetic nanoparticles.155 The NPs were
functionalized with meso-2,3-dimercaptosuccinic acid (DMSA), which contains both
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carboxylate and thiol groups for DNA absorption. Small quantities of resulting DMSA-MNPs
can isolate DNA from blood samples with a maximum yield of 86.16%, which was shown to
be much better than that with a commercial microbead (NucliSENS-easyMAG, BioMérieux).
Several colloidal IO–based magnetic nonporous NPs were also reported to be used in the
isolation of DNA from chicken erythrocyte bacterial cells of Bifidobacterium longum. The
isolated DNA was tested and quantified by PCR amplification and used for the identification
of Bifidobacterium bacterial strains.156 In the case of proteins and peptides, the magnetic
particles can couple with an appropriate affinity ligand or biopolymers to exhibit the affinity
interaction toward the target. The particles can then be added to the sample matrix to bind with
the target. In another approach, the respective antibody has been used as a free affinity ligand
and added to the samples to unite with the antibody-specific target proteins or peptides.
Magnetic particles are then functionalized with a secondary antibody (e.g., protein A or protein
G) to facilitate interaction with the target–antibody complex.157 For instance, Wittrup et al.
performed an antibody-conjugated MNP–based isolation of heparan sulphate proteoglycan
(HSPG)–induced endocytic vesicles to understand the role of the GRP75 protein in the HSPGmediated endocytosis of macromolecules.158 The extracellular vesicles and exosome can also
be isolated using an antibody–MNP complex following a method similar to that for proteins.
Superparamagnetic nanoparticles are also widely used in the isolation of mammalian
and bacterial cells from complex biomatrixes. Specific cell-recognition moiety-functionalized
NPs are incubated with the cells, followed by separation using an external magnet.29 For
example, anti-CD4 antibody–functionalized IONPs were used to isolate and separate the CD4+
T cells from human blood samples. The anti-CD4 antibody has a specific affinity to CD4+ T
cells. Thus, anti-CD4 IONPs precisely capture the T cells. The cells were then captured with a
magnet, and cell-purification efficiency was tested by using mass spectrometry through
assessment of the T cell peptide mass fingerprints.159 Cell-specific ligands (e.g.,
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oligonucleotides or peptides) such as aptamers are also used in the recognition and isolation of
cancer cells using MNPs. Aptamer (specific sequence for acute leukemia cells)-modified
MNPs were reported to develop a rapid collection and detection platform for acute leukemia
cells from whole blood samples. In this strategy, the aptamer was modified with iron oxide–
doped NPs and used to extract the target cells, while aptamer-tagged fluorescent NPs were used
to detect the target cells.160 The separation of apoptotic cells can also be achieved by using
streptavidin-modified MNPs. The apoptotic cells express the phosphatidylserine receptors (not
revealed by a healthy cell), which can specifically bind to annexin V.161 Thus biotinylatedannexin V-labeled apoptotic cells can bind to streptavidin-modified MNPs via the accessible
avidin–biotin interaction. This MNP–cell complex can be easily separated and collected using
a magnet before visualization of the cells.162 Though MNP-based isolation and preparation has
many advantages (e.g., being inexpensive, sensitive, and reusable), the method is relatively
time consuming due to the multiple steps involved in the isolation and separation process.
However, the processing time can be reduced by integrating the isolation and separation
method into a microfluidic device using free-flow magnetophoresis.163 Chen et al. have
developed a POC viral assay to purify and concentrate whole-particle HIV-1 (human
immunodeficiency virus) from plasma samples by using a microfluidic magnetic separator
chip. In this method, the anti-CD44 antibody was conjugated with a superparamagnetic NPs.
Virus-containing plasma was then mixed with antibody MNPs to obtain an HIV–MNP
conjugate. The conjugate was then passed through a packed bed of IO particles, and an external
magnet was applied to magnetize the bed, which trapped the HIV–MNP conjugates, thereby
separating the viral protein with a 62% extraction efficiency and 80-fold concentration.164 In
addition to biomolecules, MNPs can be used to adsorb heavy metals such as arsenic from the
aqueous environment, and even bare MNPs (without surface coverage) can be used to separate
pollutants from wastewater via nonspecific interactions.165
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4.2. Development of a detection platform (sensor and biosensor)
The application of superparamagnetic NPs to the development of a sensing and detection
platform is highly advantageous, as most of the biological species are nonmagnetic (they
possess inherited low background noise), and their size is analogous to that of the biomolecular
targets (e.g., DNA, protein, cells, and exosomes).28 Therefore, MNPs can be easily integrated
with biomolecules that have a lower steric hindrance, and such an interaction can be easily
controlled by controlling the NP morphology and sensor fabrication steps. Several magnetic
metal NPs, metal oxide NPs, nanowires, and composite materials have been reported to have
potential for use in a wide variety of biosensors for a broad range of bioanalytical
applications.41, 166 MNPs with a different size, nature, morphology, and composition can play
significant roles in diverse sensing platforms. Figure 7 schematically represents the critical
function of MNPs that can be achieved when they are integrated into a sensor platform, and
the details of each feature will be discussed in the following sections.

Fig. 7 The function of superparamagnetic nanomaterials in a biomolecule detection platform
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4.2.1. Immobilization of biomolecules
Immobilization of biomolecules has been considered a critical step in biosensor design, as the
direct adsorption or attachment of biomolecules onto bulk materials results in the denaturation
or decrease of their activity.167 Therefore, traditional approaches to the immobilization of
biomolecules in sensing platforms have been dramatically improved in recent years by the
inclusion of magnetic and superparamagnetic NPs. Nanomaterials offer a larger surface area
for enhanced biomolecule loading, have a greater ability to adsorb biomolecules and reduce
the diffusion limit of biomolecules on the transducer surface.168 The prerequisite requirement
for biomolecule (e.g., protein or enzyme) immobilization is that the particles should provide
an inert and biocompatible environment so that NPs cannot interfere with the native structure
and function of target species.169 Therefore, in recent decades, we have witnessed a significant
number of studies on designing bioactive nanomaterials and their application as an
immobilization platform in biosensing.170-172 Among all materials, superparamagnetic NPs
have been used extensively to immobilize and capture biomolecules or analytes (direct
attachment) on a transducer surface.173-175 In addition to the high surface area, high binding
capacity, and high catalytic specificity of superparamagnetic materials, MNPs provide for the
easy capture of biomolecule-modified NPs on the transducer surface. There are four principal
methodologies to link biomolecules (proteins or enzymes) with NPs. As shown in Fig. 8, these
are electrostatic adsorption, covalent attachment, affinity-based immobilization, and direct
conjugation to the NP surface.176
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Fig. 8 General strategies for the immobilization of MNPs with biomolecules. Reproduced with
permission.
The electrostatic interaction (through the intrinsic charge of NPs and biomolecules)
approach is widely used, and such an interaction between NPs and proteins can be easily
modulated by the ionic strength and pH of the medium. Covalent attachment (NPs modified by
primary amine or carboxylic groups) is another frequently used method of NP–protein/enzyme
conjugation, and the conjugation is greatly improved by controlling the surface chemistry of
the NPs and reaction media. For instance, a ferric oxide nanomaterial can be coated with a
polymer (e.g., PEKY), which facilitates the covalent attachment to a monoclonal antibody.177
It can also be coated with dextran to bind peptide sequences.178 In addition to NP surface
coating, the NP surface can be modified with thiol chemistry followed by the covalent addition
of proteins, enzymes, or antibodies.179 Wang and Lee proposed a method for the direct binding
of proteins onto superparamagnetic Fe3O4 through carbodiimide chemistry. They activated the
Fe3O4 surface with two kinds of carbodiimide, cyanamide and N-ethyl-Nˊ-(3-dimethylamino35

propyl)carbodiimide (EDC), followed by immobilization by two model proteins, trypsin and
avidin. The immobilization was increased by increasing the molar ratio of the EDC/NPs, and
NP activation with EDC gave a higher yield of immobilization than cyanamide did. The avidinbound NPs were bound to a biotinylated ssDNA and hybridized with a DNA probe to form a
DNA sensor.180 The avidin (streptavidin)–biotin interactions are the most robust noncovalent
affinity interactions and using this specific affinity; avidin coated NPs can selectively bind with
biotinylated proteins or disease-specific antibody modified NPs can bind with the selective
target proteins.181 Protein can also be directly conjugated with the NPs using a linker, and such
conjugation is desirable when NPs are used in the preparation of sensors involving electron
transfer. Composite nanomaterials containing Au or Ag are usually used to bind biomolecules
in this approach. For instance, Au or Ag can be bound to a protein using a cysteine residue of
proteins through Au–thiol/Ag–thiol chemistry. Lately, biomolecule (e.g., proteins, DNA,
RNA)–gold direct adsorption (the affinity interaction of DNA/RNA/proteins with gold) has
also been considered a more promising method to adsorb biomolecules over unmodified gold
NPs or gold surfaces.20, 133 Though a number of significant studies have been carried out and
streptavidin-modified MNPs (e.g., magnetic beads or protein-G magnetic beads) are
commercially available, the application of magnetic beads in a sensor platform suffers from a
lack of reproducibility and renewal of transducer surfaces. In this regard, nanoporous
superparamagnetic materials containing different bioactive materials could be a possible
solution, as they will not require complex chemistry and would have a large surface-to-volume
ratio, strong magnetic affinity, and reusable surface morphology.
4.2.2. Electrocatalytic signal amplification
With the growing demand for the trace amount of biomolecule detection, several signalamplification strategies have been developed. These strategies include the polymerase chain
reaction, mass spectrophotometry, label-amplified signal enhancement (electroactive
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molecules, different redox molecules and metal ions) and the integration of enzyme-mediated
signal-amplification strategies.182,

183

Although these methods offer adequate sensitive

detection, they are time consuming, destructive, depend on costly detection approaches, and
require highly skilled professionals. Integration of the signal-amplification properties of NMs
into the sensing platform opens the door to ultrasensitive and selective detection due to their
inherent catalytic and conductive properties. The NMs generally act as a catalyst to trigger
enhancement of the detectable signal. NP electrocatalysis is highly adaptable and can be readily
scaled for the ultralow amount of biomolecule sensing. The biocompatible NMs can produce a
synergistic effect between the conductivity and catalytic activity to accelerate the signal
transduction events, resulting in the lowering of detection limits even at zeptomolar levels.184,
185

Moreover, the accelerated signal-transduction events broaden the gap between the two

successive concentrations in a range of 5–6 orders of magnitude. For instance,
superparamagnetic NPs based on a highly sensitive, ultralow protein detection approach have
been reported by Krishnan et al. In this method, antibody-labeled superparamagnetic NMs were
used for signal amplification in a surface plasmon resonance (SPR) immunoassay for the
detection of a cancer biomarker, a prostate-specific antigen (PSA) in the serum. A monoclonal
antibody, ab2, was first conjugated with a superparamagnetic particles (MP) (Dynabeads,
Invitrogen), followed by the formation of MP–Ab2–PSA particles. As can be seen in Fig. 9,
the MP–Ab2–PSA bioconjugates were then applied to a PSA-specific antibody (ab2)
immobilized Au-SPR chips. The SPR signal was monitored constantly after the addition of
MP–Ab2–PSA bioconjugates and the SPR signal quantify a and ultralow amount of PSA with
a detection limit of 10 fg mL-1 (ca. 300 aM).186
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Fig. 9 Schematic representation of an SPR immunosensor based on clustered magnetic NMs
for signal amplification. Reproduced with permission.186
In constructing electrochemical sensors, one of the crucial requirements is electrical
contact between the electrode surface and redox biomolecules. Generally, the active sites of
biomolecules are surrounded by a thick protein shell, which blocks the direct electron transfer
between biomolecules and the electrode surface. Metal NPs can resolve the barrier and enhance
the rate of electron transfer due to their high conductive properties. In those circumstances,
MNPs could be potential supporters for an extensive loading and magnetically controlled signal
trace with ultrasensitive detection. For example, iron oxide–based NPs were employed as a
signal enhancing element for the electrochemical immuno-sensing of carcinoembryonic
antigen (CEA). The three-layer MNP Au–PB–Fe3O4 (Fe3O4 magnetic core, PB as an interlayer,
and gold as a shell) was functionalized with a bioenzyme (HRP and glucose oxidase), and it
exhibited excellent redox electrochemical activity and superior enzyme catalysis activity
toward glucose in an immunoassay of CEA and α-fetoprotein (AFP). The sensor can detect 4
pgmL-1 and 7 pgmL-1 of CEA and AFP, respectively. An external magnet could be used to
isolate NPs, with subsequent magnetic purification to make the sensor reproducible and
reusable.187 A similar sandwich-type immunoassay has been reported for ultrasensitive
detection of the carbohydrate antigen (CA-125), and AFP based on the magnetic NMs as a
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signal amplifier.188 Silica NPs and silica-coated magnetic materials can also be used as carriers
for signal amplification in the development of an ultrasensitive immunoassay due to the small
size, high surface-to-volume ratio, and excellent biocompatibility of silica.189, 190
4.2.3. Signal-generating probes
The labeling of biomolecules in the construction of biosensor is a common strategy for
obtaining output signals. In the most conventional approaches, different enzymes, redox
molecules, electroactive molecules, and metal ions have been used as a signal generation
label.191 [Note: Is this okay, or do you mean “…used as signal generation labels.189”?] The
natural enzymes possessed poor stability under environmental stress, and sensor design had a
high cost. The application of redox molecules as a label is a popular approach, but it has been
limiting their application, as it can only transfer a few electrons (or even just one), which
directly affects the sensitivity of the biosensor. The integration of biofunctionalized NMs as a
label to obtain a signal, especially an electrochemical signal, has opened new prospects in
biosensing. [Note: Is this okay, or do you mean “…NMs as labels to…”?] The NM label
generated an enormous signal, which is associated with the ultrasensitive detection of an
ultralow number of biomolecules. The biomolecule generally attached to or modified to the
biocompatible NMs, and hence retained their activity to interact with its counterpart. There are
two strategies by which NMs generate signals: (i) they load an increasingly large number of
target biomolecules, and (ii) they act as an ultramicroelectrode array for the electrolysis of a
bulk amount of substrates.166 NMs generally contain a great many electrochemically active
elements (or atoms), thereby increasing the loading of electroactive species onto the transducer
surface and enhancing the sensitivity of the readout system. For instance, a flow injection
chemiluminescence (FI-CL) assay for the detection of DNA hybridization was developed based on
a biobarcode-functionalized MNP label. As can be seen from Fig. 10, MNPs are functionalized with
amino-modified probe DNA (pDNA) and biobarcode DNA (bbcDNA) to form bbc-p-DNA-MNPs.
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The target DNA (tDNA) was captured on a capture DNA–assembled (cDNA) gold electrode
surface. The bbc-p-DNA-MNPs were then allowed to hybridize with the overhang region of pDNA
through pDNA–tDNA hybridization. The bbc-p-DNA-MNPs were dissolved in nitric acid solution,
which releases a large number of ferric ions. Thus ultrasensitive detection of a DNA hybridization
event was achieved by the luminol–H2O2–Fe3+ CL free-radical reaction system.192

Fig. 10 Schematic representation of a biobarcode-functionalized MNP label–based
chemiluminescence detection of DNA hybridization (A); the flow injection chemiluminescence
readout system for the quantification of Fe3+ (B). Reproduced with permission.192

Iron oxide and some other promising MNPs catalyze common chromogenic substances and
efficiently enhance the detection signal in immunosorbent assays. The cascade reactions are highly
sensitive to the pH of the detection buffer, temperature, and time, resulting in a time-consuming,
dose-dependent reaction and poor reproducibility. The integration of MNPs as a signal-generation
and amplification label in a colorimetric assay could give better and more detection, as the assay is
independent of the cascade reaction as well as such reaction conditions. The released ions from
MNPs generated an enhanced signal intensity, which is directly linked to the level of target

40

biomolecules. Recently, Zhang et al. developed a colorimetric immunoassay for the sensitive
detection of a cancer biomarker carcinoembryonic antigen (CEA) based on a ferric oxide MNP as a
signal generator and amplifier label. Herein, an antibody (ab1) was loaded into a high-binding 96well microplate, followed by the addition of a target CEA. An antirabbit IgG (Ab2)–functionalized
MNP was then added to form a sandwich-like immunocomplex. The MNP, acting as an iron pool,
released a large amount of Fe2+ when it was dissolved in a mixture of bathophenanthrolinedisulfonic
acid disodium salt (BPT) and ascorbic acid (AA). The Fe2+ generated a stable red solution, which
gave a naked-eye and quantitative evaluation through colorimetry results in the sensitive detection
of CEA with a limit of detection (LOD) of 3.6 pg mL−1.193. Another exciting application of MNPs
is to design novel magneto-switchable electrodes with unique properties. Various MNPs, nanorods,
and nanosheets have been used to turn on or off the electrochemical reactions, depending on the
physical translocation and orientation of the MNPs in response to the direction of an external
magnetic field.194, 195 The electrochemical reaction is triggered by the reposition of an external
magnet, resulting in a change in the magnetic field strength of the electrode interface. Willner et al.
presented

an

alkyl-chain-functionalized

MNP–based

magneto-switchable

hydrophilicity/hydrophobicity-controlled electrode surface. As can be seen from Fig. 11, the
two-phase platform consists of a gold electrode with an aqueous buffer solution and an organic
(toluene) phase located on the electrode surface. Hydrophobic superparamagnetic Fe3O4 NPs
were used to regulate the interfacial properties of the electrode surfaces. When a magnet was
placed below the electrode, the hydrophobic MNPs were pulled down from the upper toluene
layer into the aqueous layer, resulting in the formation of a membrane-like film on the surface,
thereby inhibiting the interfacial electron transfer to create an “off” state. The “on” state was
achieved by placing the external magnet above the electrode surface, which pulled the MNPs
up from the aqueous to the organic phase, allowing contact of the redox probe (e.g., ferrocene
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or ferrocyanide dicarboxylic acid) with the electrode surface and facilitating the oxidation
process.196

Fig. 11 Magneto-controlled reversible translocation of the functionalized MNPs between the
organic phase above the aqueous electrolyte and the electrode surface. (A) A magnet below the
electrode surface pulls the hydrophobic MNPs, forming a membrane-like layer on the electrode
surface (“off” state); (B) a magnet positioned above the electrode returns the MNPs to the
organic phase, resulting in the generation of an electrochemical reaction (“on” state).
Reproduced with permission.196

A photoelectrochemical current can also be generated and magnetically controlled via
magnet-bound quantum dots. With DNA hybridization, the biocatalytic reaction can be
controlled using capture probe–functionalized MNPs directed to and from the electrode
surface.197,

198

In the most refined magneto-switchable electrode systems, the activity of

electrodes was regulated (activation or inactivation) by complex multi-enzyme systems or
different biochemicals added to solutions, thereby mimicking the biological event and
properties.199, 200
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4.3. Nanocarriers
Due to their tremendous magnetic nature, biocompatibility, and high surface area, magnetic
NMs are becoming excellent candidates for carrying agents in numerous biomedical
applications, such as magnetic guided drug delivery, the separation of magnetically tagged
DNA, the identification of biological species, magnetic resonance imaging, and cancer
therapies.32, 201, 202 NMs can also be used to support the isolation system for concentrating the
target biomolecules or high-level loading of signal molecules. Generally, single-wall carbon
nanotubes (SWNTs) have been used to anchor probe DNA in the transducer surface when
constructing a hybridization-based sensor. For a DNA sensor, the target DNA was hybridized
with the probe DNA. Based on the decreasing DPV response to the guanine base of DNA, the
target DNA can be quantified.203 Magnetic NMs can easily concentrate and purify the target
and hence dramatically enhance detection sensitivity. For instance, Wanunu et al. reported the
nanopore-based electronic detection of microRNAs based on a protein-functionalized magnetic
bead. In this assay, the target miRNA was first hybridized with a capture probe to form a probemicroRNA duplex. The duplex was allowed to bind with protein p19–functionalized magnetic
beads. The magnetic beads authorized the ultrahigh enrichment of the duplex and purification
of the duplex from the RNA pool. The suplex was then eluted and electronically detected by
using a nanopore system. The magnetic bead produced 100-fold enrichment of the duplex and
enabled pictogram-level detection of liver-specific miRNA from rat liver miRNA.204 Aucontaining NMs have also been used as carriers for target or signaling molecules. For instance,
AuNPs-coated Fe3O4 NPs can serve as a reusable carrier for the immobilization of
biomolecules (enzymes).205 Introducing pores into magnetic NMs can tremendously enhance
the surface area and significantly improve the functionalization with biomolecules, drug
loading, concentrating target molecules.206 Therefore, porous magnetic NMs containing
AuNPs could provide a great platform as carriers of different biomolecules. Recently, Sharda
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et al. developed a new class of gold-loaded superparamagnetic NMs (Au@NPFe2O3) as a
dispersible capture agent for the naked-eye and electrochemical detection of cancer-specific
autoantibodies. As can be seen in Fig. 12, the synthesized Au@NPFe2O3 nanocubes were
functionalized with the p53 protein, followed by the dispersion of p53 protein–functionalized
NMs into the serum samples containing target p53–specific autoantibodies. The higher surface
area of superparamagnetic NMs facilitates the bindings of higher amount of target, and
purification and isolation of target as well. The horseradish peroxidase (HRP)–modified IgG
(secondary antibody) then bound with the target and was used to catalyze the oxidation of the
3,3,5,5’-tetramethylbenzidine (TMB)/H2O2 system. The generated color indicates the
presence of a p53 autoantibody, and subsequently, the amount was quantified by colorimetry
and amperometry.207 Simillarly, different magnetic NMs are also utilized in microfluidics and
lab-on-chip systems as a carrier of target molecules, target-binding proteins, or signaling
molecules.

Fig. 12 Schematic representation of the detection of p53 autoantibodies based on a
superparamagnetic Au@NPFe2O3 nanocube as a dispersible nanocarrier. Reproduced with
permission.207
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4.4. Natural enzyme mimetics: Nanozymes
Nanozymes is a term referring to the NMs that exhibit natural enzyme-like activity to catalyze
the oxidation reaction of various organic substances (e.g., chromogenic substances).208, 209
Nanozymes have been considered an excellent alternative to natural enzymes in the fields of
biosensor development, nanomedicine, and environment remediation due to their much higher
stability, easy storage, and lower cost.210-212 With the tremendous advancement in nanoresearch
and distinctive properties of NMs, a wide range of NMs (e.g., ferromagnetic NPs, gold NPs,
rare earth NPs, metal complexes, and polymers) have been developed to exhibit peroxidase-,
oxidase-, catalase-, superoxide dismutase-, and lactase-like activities.213-215 Among these NMs,
iron oxide-based MNPs are highly advantageous in bioanalysis due to their chemical and
biological inertness, easy surface modification, and magnetic field–based separation efficiency.
In 2007, Yan et al. discovered that, surprisingly, Fe3O4 NPs possess an intrinsic peroxidasemimicking activity that catalyzes the oxidation of three chromogenic substances named TMB,
DAB (di-azo-aminobenzene), and OPD (o-phenylenediamine).208 The experiment showed that
the Michaelis–Menten constant (Km) value of MNPs with TMB was about four times lower
than that of those with HRP, indicating that NPs have higher catalyzing activity for the
oxidation of TMB. This is because HRP contains only one iron ion, in contrast to a large
amount of Fe2+ and Fe3+ on the surface of NPs. However, the Km value of NPs with H2O2 (as a
substrate) was significantly higher than that of those with HRP, demonstrating that a higher
amount of H2O2 was required to achieve the maximum mimicking activity. Like natural HRP,
the activity is highly dependent on the pH and temperature of the reaction buffer. Moreover,
the NP size influences the activity: the smaller the particle size, the more activity was observed,
as smaller NPs possess a higher surface-to-volume ratio to interact with the substrates. The
mimetic activities are generally performed by the generation of a hydroxyl free radical from
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H2O2 following the Fenton reaction (as shown in equations 1–3), and subsequent oxidation of
TMB (equation 4) is carried out by the generated hydroxyl free radical.216-218
Fe3+ + H 2O2 → FeOOH 2+ + H +

(1)

FeOOH 2+ → Fe 2+ + HO2 

(2)

Fe2+ + H 2O2 → Fe3+ + OH − + OH

(3)

 OH + TMB → TMBox (Blue )

(4)

The reaction mechanism is considered to be the ping-pong mechanism, as no tertiary
intermediate is formed between the NPs and the two substrates (the product from one substrate
is dissociated before the second one binds). Moreover, the steady-state kinetic experiment
showed that the substrate concentration-dependent double-reciprocal (Lineweaver–Burk) plot
was parallel, which is characteristic of the ping-pong mechanism.
Inspired by Yan’s discovery, many researchers have worked to develop a colorimetric
sensing platform of H2O2, glucose, cysteine, etc., based on the MNP peroxidase mimetic
activity using TMB and ABTS (2,2'-and-bis(3-ethylbenzothiazoline-6-sulphonic acid) as
substrates. For instance, Wei et al. developed a colorimetric platform for the detection of
glucose using Fe3O4 as a nanozyme and ABTS as a substrate. The oxidized ABTS generated a
green product, which enabled naked-eye detection. The colorimetric readout can detect H2O2
as low as 3 mM and glucose as low as 3×10-5 mol/L.219 Later, H2O2 detection was used to detect
several ions, glucose, etc. In addition to ABTS, other chromogenic substances, such as TMB,
4-AAA-phenol, OPD, and DPD, have also been used, and it has been shown that TMB gives
more selective and sensitive detection than ABTS, as H2O2 can oxidize ABTS even in the
absence of peroxidases.220 Doped ferrites such as Prussian blue/Fe2O3, CoFe2O4,
graphene/Fe2O3, ZnFe2O4, and CoF2O4 had also been explored as peroxidase mimetics for the
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detection of H2O2, glucose, L-cysteine, etc.221-224 For instance, CL detection of H2O2 and
glucose was performed using CoFe2O4 MNPs. The CoFe2O4 MNPs efficiently catalyzed the
decomposition of H2O2 into hydroxyl free radicals (·OH), which subsequently catalyzed the
oxidation of luminol. Coupling the NP-catalyzed CL reaction of luminol–H2O2 with the glucose
oxidase–catalyzed glucose oxidation reaction enabled CL detection of glucose from blood
samples with a detection limit of 0.024 µM.224 Apart from iron oxide–based NMs, other
nanomaterials, such as AuNPs, CuONPs, Eu2O2SNPs, AgX (X= Cl, Br, I), polyoxometalates,
PtNPs, carbon nanotubes, and nanodots, have been exhibited peroxidase-like activity.225-227
One of the major challenges of MNPs is the specificity of nanozymes, as NPs do not have a
binding pocket (active sites). The catalytic reaction of nanozymes takes place at the surface;
thus there is a possibility of substrate diffusion to the surface that can react with all substrates,
irrespective of substrate shape and size. Many approaches have been utilized to introduce
substrate specificity or a molecular-recognition function. These approaches include attaching
aptamers, antibodies, peptides, or molecular imprinting. Among them, molecular imprinting
has been considered superior to biological ligands, as biological substances are less stable,
easily denatured, and expensive and require sophisticated operations. Molecular imprinting
refers to the polymerization of a monomer (complement to the template) around template
molecules to form a prepolymer binding complex.

228

Very recently, Zhang et al. grew

molecular imprinted polymers on Fe3O4 to form substrate binding pockets and measured
peroxidase-like activity toward the oxidation of TMB and ABTS. Moderate enhancement of
the specificity and catalytic activity was achieved by imprinting with a neutral monomer.
However, when imprinting with a charged monomer, the catalytic activity increased
dramatically, 100-fold, compared to that of the bare Fe3O4.229 Another limitation of MNPs for
biosensing is associated with the fact that most of these materials demonstrate their highest
peroxidase-like activity at a high temperature (40–45 °C), which limits their application in
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disease-specific biomolecule detection at room temperature. Therefore, a highly porous
framework of MNPs with high specificity could offer enhanced peroxidase-mimetic activity
even at room temperature.

5. Application of superparamagnetic nanoparticles in biomolecular detection

5.1. Electrochemical biosensors
Electrochemical techniques have aroused great interest in constructing biosensors for the
detection of biomolecules, as the electrochemical biosensors offer sensitive, highly selective,
portable, easy-to-operate, and stable operation as well as fast detection. In electrochemical
sensors, electrode materials play a critical role in obtaining high-performance sensing
platforms via various analytical principles, such as voltammetry (CV, DPV, LSV, etc.) and
amperometry (i-t). Incorporating superparamagnetic nanomaterials into common electrode
materials not only can produce a synergistic effect among biocompatibility, magnetism,
catalysis, and conductivity but also can provide accelerated signal transduction and amplified
biorecognition events, resulting in an ultrasensitive biosensing platform. In recent decades,
significant research has been conducted on the construction of various magnetic materials, such
as the construction of functional electrode surfaces as signaling tags or as electrocatalysts,
giving rise to advanced electrochemical biosensors. For example, Zhu et al. highlighted recent
advances in nanomaterial-based electrochemical sensors and biosensors. Electrochemical,
nonelectrochemical, magnetic, and chemical optical sensors and biosensors based on
nanocrystalline iron oxides and their composites have also been highlighted by Urvanoba et
al.41, 49 In this section, we mainly focus on the advances of nanostructured superparamagnetic
materials-based electrochemical nucleic acid assays, immunoassays, and cytosensing
platforms.
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5.1.1. Nucleic acid assay
The detection of target sequences of nucleic acids (DNA or RNA) has aroused considerable
attention due to their wide application in gene therapy, molecular diagnostics, epigenetics,
pathogen detection, and early screening of malignant diseases, like cancer. Highly sensitive
and specific detection is desirable, as the DNA levels are scant in most of the diagnostic
specimens, such as cancer, infectious diseases, or pathogens. In recent decades, several
electrochemical DNA/RNA detection platforms have been developed with high selectivity,
excellent sensitivity (attomolar detection limit), and on-site measurements.230 Most of the
standard DNA biosensors consist of a single-stranded (ss) capture probe immobilized onto the
sensing surface for the hybridization of target sequences with electrochemical tags for signal
generation.6 Several amplification strategies have been utilized to achieve ultrasensitive
detection. Natural enzyme (e.g., alkaline phosphatase (ALP) and HRP)–assisted amplification
(enzymatic catalytic reactions) has been widely used for this purpose.231, 232 The integration of
magnetic materials with such amplification not only can enhance sensitivity and selectivity but
also offers a low-cost miniaturization platform. For example, an HRP-modified Fe3O4 NP (as
a signal amplification source)–based sequence-specific DNA sensor has been proposed by
Dong et al.233 In this sensor, HRP was adsorbed onto the NP surface through layer-by-layer
(LbL) techniques, followed by the loading of Au-NPs to obtain Au-HRP-Fe3O4 conjugates. A
signal probe and diluting probe sequences were then added to form DNA–Au–HRP–Fe3O4
(DAHF) bioconjugates. As shown in Fig. 13, the capture probe was immobilized on a freshly
prepared gold nanofilm electrode surface to hybridize target DNA (two-base mismatched
DNA). In the presence of target DNA, the DAHF bioconjugates attached to the GNF surface
via the hybridization of target DNA with a diluting probe sequence. An HRP-catalyzed TMB
oxidation reaction was then carried out to amplify the chronoamperometric signal. In
conjunction with gold-coated ferric-oxide NPs and streptavidin peroxidase–induced signal

49

amplification, Loaiza et al. have developed similar electrochemical DNA sensors for the
detection of specific DNA hybridization events.234 High sensitivity in such hybridization-based
DNA detection can be accomplished by the utilizion of optimum hybridization conditions, the
design of the capture and signaling probe, and the elimination of nonspecific bindings in the
transducer surface. A peptide nucleic acid (PNA) probe has been known to possess excellent
sequence-specific affinity and stability in the recognition of target sequences as they maintain
equidistance between nucleobases, rigid amido bonding, flexible amino-ethyl linkers and
intramolecular hydrogen bonding, MNPs have also been immobilized with a PNA probe for
the construction of DNA sensors based on PNA-DNA hybridization.235

Fig. 13 A magnetic Fe3O4–based sandwich-type detection strategy for two-base mismatched
DNA detection. Reproduced with permission.233
miRNA is a small noncoding RNA that post-transcriptionally regulates gene expression
by modulating downstream proteins, thus acting as a potential diagnostic and prognostic
biomarker of various diseases, including cancer. Several conventional approaches, such as
northern blotting, in situ hybridization, microarrays, and quantitative real-time PCR (qRTPCR), and several biosensors have been applied successfully. Though each of these methods
has superior detection sensitivity, the conventional approaches rely on either PCR-based
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amplification or fluorescent labeling and expensive, complicated procedures.236 In recent
decades, several electrochemical and optical biosensors have been developed that may give
superior analytical performance; yet they still rely on complex and tedious amplification
processes, expensive biomaterials, and time-consuming and difficult procedures. Recently,
nanomaterials have been merged with conventional biosensors to create an easy and
inexpensive miRNA detection platform. For example, carbon nanotube (CNT) and single-wall
carbon nanotube (SWCNT) nanowires have been widely used in electrode design.237 Recently,
we described the synthesis of specially engineered superparamagnetic gold-loaded nanoporous
iron oxide nanocubes (Au@NPFe2O3NC) and an amplification-free, nonenzymatic, and
sensitive miRNA detection platform45 based on the magnetic, electrocatalytic, and miRNAadsorbing properties of these nanocubes. The nanocubes showed excellent electrocatalytic
activity toward the reduction of redox molecules Ru(NH3)6Cl3. As can be seen from Fig. 14,
the nanocubes have been attached to a screen-printed carbon electrode (SPCE) with the help of
an external magnet without any complex electrode modification steps. Target miRNAs were
physically adsorbed onto the gold NPs of nanocubes via RNA–gold affinity interactions. The
amount of miRNA adsorbed onto the nanocubes was quantified by chronocoulometric (CC)
charge interrogation in the presence of a signaling redox molecule [Ru(NH3)6]3+. The assay can
successfully detect a 1 pM level of miRNA (miR-21) in tissue samples derived from patients
with esophageal squamous cell carcinoma (ESCC). In order to achieve more sensitive detection
of miRNA, we recently reported another biosensor design, wherein a redox molecule
[Ru(NH3)6]3+ coupled with another redox molecule [Fe(CN)6]3- to create an electrocatalytic
redox cycle.238 The CC signals for the electrocatalytic reduction of [Ru(NH3)6]3+ were
amplified by further reduction of the solution-phase [Fe(CN)6]3-. Here, as the [Fe(CN)6]3- in
solution is a stronger oxidant, it initiates the electrocatalytic cycle via the oxidation of reduced
[Ru(NH3)6]2+ for the regeneration of [Ru(NH3)6]3+. The redox cycle–induced signal-

51

enhancement steps enhance the detection sensitivity up to 100 aM for the detection of miRNA
(miR-107) from cancer cell lines and a panel of tissue samples derived from patients with
ESCC. This design could be integrated into a microfluidic device to achieve a low-cost, simple,
ultrasensitive miRNA sensor.

Fig. 14 Superparamagnetic nanoparticle–based miRNA sensor. The target miRNA (miR-21)
was initially extracted from target cell lines or tissue samples, followed by magnetic beadbased isolation and purification. The target miR-21 was then directly adsorbed onto the
nanocube-attached SPCE. An enhanced electrochemical signal was generated by the CC
interrogation of stoichiometrically bound [Ru(NH3)6]3+/2+ complexes with nanocube surface–
bound miRNA. Reproduced with permission.45

5.1.2. Immuno assay
Electrochemical immunosensors are a specific antibody–antigen interaction (noncovalent)–
based detection platform in which the immunochemical reaction event is coupled to a signal
transducer. Generally, an enzyme-labeled antibody or antigen is immobilized at the electrode
surface to perform a sandwich-mode operation. Voltammetric or amperometric detection is
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used to accomplish the conversion of biorecognition events into an analytically significant
electrochemical response.239 In MNP-based electrochemical immunosensors, the recognition
element is immobilized with the NPs, which are later used for either electrode modification or
as signal-generating probes. MNPs have generally been polymerized to obtain a thin polymer
shell so they can be easily functionalized with antibodies, redox molecules, or any linking
groups.240 For example, an ultrasensitive sandwich-type electrochemical immunosensors for
the detection of a cancer biomarker; prostate-specific antigen (PSA) have been reported based
on ferrocene-modified magnetite NPs.241 Ferrocene-functionalized MNPs and graphene sheets
were used as the electroactive label and sensing platform, respectively. Graphene sheets were
chosen, as they offer an enhanced surface area for capturing a larger amount of primary
antibodies (Ab1) and for the sensitive detection of ferrocene. In this assay, dopamine (DA) was
first anchored to the magnetite surface, followed by the conjugation of ferrocene
monocarboxylic acid (FC) and a secondary antibody (Ab2) onto Fe3O4 through the amino
groups of DA (DA-Fe3O4−FC-Ab2). The high number of DA molecules anchored to the Fe3O4
surface increased the immobilization of ferrocene and Ab2 onto the magnetite NPs, which in
turn increased the sensitivity of the immunosensor. In another report, functional
nanocomposites of Au and Ag core–shell magnetic graphene loaded with a cadmium ion
(Au@Ag/GS-Fe3O4/Cd2+)–based immunosensor were used for the detection of IgG.242 The
amino-functionalized magnetic graphene nanocomposites (NH2-GS-Fe3O4) were used to bond
Au and Ag core–shell NPs (Au@Ag NPs) followed by the adsorption of a cadmium ion (Cd2+).
The Au@Ag/GS-Fe3O4/Cd2+ increases the electrocatalytic activity toward hydrogen peroxide
(H2O2) and improves the effective immobilization of antibodies. The sensor can detect the IgG
with a detection limit of 2 fg/mL.
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5.1.3. Cytosensors
In electrochemical cytosensors, a biocompatible recognition unit is fabricated onto the
electrode surface to specifically recognize the target cells, followed by coupling with a
sensitive electrical readout. Varieties of specially engineered nanomaterials have been shown
to anchor target-cell recognition units, such as aptamers, antibodies, or receptors, as well as to
report enhanced cell-recognition events. For example, Au NP–decorated magnetic Fe3O4
nanoprobes were reported for the construction of an electrochemical cytosensor for the
detection of leukemia cells and the quantitative estimation of death-receptor expression on
leukemia cell surfaces.243 The nanoprobes were assembled through the co-immobilization of
both rhTRAIL (recombinant human TRAIL) and HRP on Au NP–Fe3O4 beads. The rhTRAIL
had been used for specific and selective recognition of DR4/DR5 on leukemia cell surfaces,
and an amplified electrochemical signal was achieved via HRP catalyzation of the oxidation of
thionine by H2O2, resulting in the sensitive detection of leukemia cells with LOD ∼40 cells. In
a later year, nonenzymatic nanoelectrocatalysts, Fe3O4@nanocage (Ag-Pd) core-satellite
hybrid NPs, were engineered by the same research group as signal-amplifying nanoprobes for
the ultrasensitive detection of low abundant circulating tumor cells (CTCs).244 CTCs have been
considered a valuable biomarker for early diagnosis of cancer, as they play critical roles in
metastasis. As can be seen from Fig. 15(A), the nanoelectrocatalysts were prepared via the
electrostatic interaction between positively charged (as synthesized) Fe3O4/PDDA (di-allyldimethyl ammonium chloride) and negatively charged Ag−Pd nanocages. Fe3O4@Ag−Pd
hybrid particles were shown to be highly catalytically active toward the electrochemical
reduction of a redox dye; thionines and the nanocage were used as signal-amplifying
nanoprobes for cytosensor design. The inherent electroactive properties of Fe3O4 and the large
surface area, high conductivity, and distinctive porous hollow structure of the Ag−Pd
nanocages contribute synergistically toward amplification of the catalytic signals. Figure 15(B)
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illustrates the steps involved in the sensor design. A GCE surface was modified with the Au
NPs, followed by the conjugation of SYL3C−SH (thiolated cell–targeting aptamers) via
Au−thiol interactions. A SYL3C-functionalized hybrid nanoprobe, SYL3C−Fe3O4@Ag−Pd,
was formed by the conjugation of thiolated SYL3C with the Ag−Pd nanocages through
metal−thiol interactions. After capturing the target cells (CTCs) onto the SYL3C-Au modified
GCE, the SYL3C−Fe3O4@Ag−Pd nanoprobes were attached to form a sandwich-resembling
superstructure. The DPV responses were then measured in the presence of thionines to quantify
the two model cells (MCF-7 and T47D) and the sensors able to detect ∼4 MCF-7 and ∼5 T47D
cells. Thiolated sgc8c aptamer–immobilized Au NP–coated magnetic Fe3O4 NPs were also
reported for the detection of leukemia cancer cells.245

Fig. 15 Schematic illustration of (A) the fabrication of Fe3O4@Ag−Pd hybrid NPs and (B)
the steps involved in sensor design for the detection of CTCs. Reproduced with
permission.244
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Sun

and

co-workers

have

engineered

a

hybrid

nanoelectrocatalyst

(Fe3O4/MnO2/Au@Pd) as both an electrochemical signal amplifier and a carrier of nanoprobes
for the sensitive detection of human hepatocellular cancer cells (HepG2).246 The nanocatalyst
was designed by the conjugation of a Au@Pd core–shell nanosphere and Fe3O4/MnO2
nanocomposite and modified with a thiolated capture probe, HRP, and hemin to form a
Fe3O4/MnO2/Au@Pd–HRP–aptamer/hemin/G-quadruplex nanoprobe. After the capturing
target cells on a thiolated aptamer–attached AuNP/GCE surface, a sandwich-like structure was
formed with the as-prepared nanoprobes. After that, an amplified DPV signal was obtained
from benzoquinone (BQ) generated from Fe3O4/MnO2/Au@Pd–HRP–aptamer/hemin/Gquadruplex nanoprobes that catalyzed the oxidation of hydroquinone (HQ) with H2O2. The
generated DPV response was directly related to the number of nanoprobes present on the
AuNP/GCE surface, thus reflecting the number of cells present in the system. Very recently,
Fe3O4NP nanozymes with reduced graphene oxide/molybdenum disulfide (rGO/MoS2)
composites have also been reported for the detection of CTCs.247
5.2. Optical biosensors
Novel metal nanostructures with a dimension below 100 nm possess numerous unique optical
properties, such as absorption, emission, surface plasmon polariton propagation, and localized
and surface plasmon resonance, in the extended visible and near infrared (IR) regions. 34, 248
Their distinct properties, including magnetism, engineered dimension, opto-electronics, and
surface functionalization with antibodies, ligands, and recognition elements capacity, make
superparamagnetic NPs superior candidates for the rational design of a sensing platform for
biomolecules with low concentration. Based on such distinctive properties and plasmonic
behaviors, numerous MNPs-based optical detection have been reported.
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5.2.1. Colorimetry and fluorescence detection
Colorimetric sensors have been considered for emerging spot-chemical detection techniques,
as they offer detection with minimal facilities due to the replacement of complicated steps and
expensive instrumentation. They can be easily integrated into the solid strips, papers,
smartphone, thus allowing portability and affordability of the detection of target samples.
Integration of MNPs with colorimetric sensors offers more sensitive, accurate, miniaturized,
cost-effective, instantaneous in situ detection of target analytes. The detection mechanism
generally relies on the functionalization of MNPs with the recognition elements (e.g.,
antibodies or aptamers), followed by the capture and magnetic isolation–purification of
targets.249,250 The purified MNP-bound target is then used to interact with a chromogenic
substance or to undergo NP enrichment to generate analyte-defined colors. For instance, antiStaphylococcus aureus (S. aureus) antibody–functionalized AuNP/MNPs have been used to
detect a food pathogen, S. aureus, in milk.251 The immunomagnetic composite was inoculated
into the milk sample to capture the target, followed by magnetic isolation and purification. The
resuspension of captured bacteria-antibody/AuNP/MNP complexes was passed through a
selective filtration system, while the target unbounded NP composite filtered through the
membrane and the target bound NP composite did not penetrate, resulting in corresponding red
spot through a gold enhancement solution. The assay can detect 1.5 × 105 CFU of S. aureus in
milk, but it required a predesigned filtration system, signal (color intensity) enhancement, and
solution treatment. Suaifan et al. reported a lab-on-a-chip (LOC) strip-based biosensor for
detecting cancer biomarker PSA protease without using any chromophore labeling or colorenhancement solution.252 In this sensor design, a PSA substrate peptide was covalently bound
to a magnetic bead and linked to the gold surface of the paper strip. The PSA protease was then
applied to cleave the strip-bound PSA substrates, resulting in the release of a black magnetic
carrier complex and thereby exposing the target corresponding gold-colored sensor surface to
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naked-eye detection. Recently, several other paper colorimetric biosensors based on the
proteolytic activity of the target have also been reported to detect food contaminants in complex
foods and milk.253, 254 However, in recent decades, many MNP-colorimetric sensors have been
reported based on the intrinsic peroxidase mimetic activity of MNPs, which is described
separately in section 5.3.
5.2.2. SPR biosensors
Surface plasmon resonance (SPR) sensors possess a unique capacity for real-time monitoring
of the interaction of biological analytes by evaluating the refractive index changes during
complex (usually sandwich-type) formation or dissociation at the SPR sensing surfaces.255 SPR
sensors have generally suffered from low signal intensity and nonspecific bindings for the detection
of trace amounts of proteins, nucleic acids, and other small biomolecules.256 To obtain signal
enhancement, several metal nanoparticles, including Au,257 Pt,258 Pd,259 and SiO2,260 have been
investigated; however, these NPs (due to their low molecular weight and slow diffusion to the sensor
surface) are unable to realize the promise of achieving highly selective and sensitive detection.
Target-specific enrichment, isolation of the target from complex biometrics, and simultaneous signal
enhancement could be a way to perform targeted and sensitive SPR-based biomolecule or biomarker
detection. Magnetic nanostructures hold promise for providing a high surface-to-volume ratio,
minimum disturbance to surface functionalization, easy and faster binding, better miscibility,
magnet-based isolation and purifications, high molecular weight, and necessarily quick delivery of
target analytes to the sensor surface through a magnetic field gradient to choke the slow, diffusiondriven mass transfer.261 By utilising Fe3O4 MNPs as amplification reagent, a sandwich SPR sensor
has been reported for detecting thrombin by utilizing Fe3O4 MNPs as amplification reagents; the
MNP–aptamer conjugates were used to accomplish the antithrombin aptamer–thrombin–MNP
sandwich on an SPR sensor, and an LOD of 0.017 nM was achieved.262 However, though the greater
mass and superior refractive index of the MNPs located in the evanescent field give rise to signal
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enhancement, the MNPs tend to aggregate and possess bad biocompatibility if it is not wellfunctionalized with biomolecules or antibody or any metallic coating through cumbersome
chemistries.96, 263 One of the prominent approaches to overcome this is to employ the well-known
surface chemistry of Au. The loading (or coating) of gold onto MNPs stabilizes the particles in
solution, enabling the straightforward binding of capture probe molecules or target biomolecules
and improving the signal enhancement by combining the refractive indexes from both Au and MNPs
(GMNPs - gold MNPs).264
Besides Au, graphene oxide (GO)–modified MNPs are also promising in SPR-based
biosensing. GO provides multiple sites for the deposition of other metal oxides, whereas the reduced
GO (rGO) provides an sp2-hybridized lamellar scaffold for carrying different proteins and probe
molecules.265 By combining both the Au and GO with Fe3O4 MNPs, an SPR sensor was developed
for detecting the human IgG protein.266 As shown in Fig. 16, the carboxyl group–functionalized GO
was employed as a sensing surface for immobilizing the capture antibody (Ab1). A magnetic
nanohybrid was formed by combining the MNPs with hollow Au NPs (HGNPs), followed by
modification with a detection antibody (Ab2). An Ab2 nanohybrid was then utilized to magnetically
collect target IgG from the sample and to rapidly deliver the target sample to the sensor surface using
an external magnet. Taking the advantages of magnetic field–driven mass-transfer, inner and
outer surfaces derived notable plasmonic fields, and the significant signal amplification of
magnetic nanohybrid the developed SPR sensor achieved a LOD of 1.88 ngmL-1 toward the
detection of IgG. Distinguished plasmonic enhancements are resulting in if the hollow gold
nanospheres (HGNPs) are electromagnetically coupled with the plasmonic effects of the inner
and outer surface of HGNPS. Based on this amplification strategy, improved SPR was reported,
in which a detection antibody (Ab2)–modified polydopamine-Ag@Fe3O4/reduced graphene
oxide (PDA-Ag@Fe3O4/rGO) was utilized to attach the target and form a sandwich structure
with the target IgG and Ab1 immobilized onto an Au surface.267 Fe3O4 facilitates the magnet59

guided sample and Ab2 collection; the PDA permitted efficient immobilization of the antibody
and prevented agglomeration. Ag NPs were excited to generate SPR, and their hot electrons
were doped on thin graphene films, which improved the response of the target IgG.

Fig. 16 Schematic representation of a GO-sensing film and Fe3O4-HGNPS- hybrid probe-based
magnetic field–assisted SPR biosensor for IgG detection Reproduced with permission.266
5.2.3. LSPR biosensor
Unlike SPR, a localized surface plasmon resonance (LSPR) biosensor depends on the light–
matter interactions of noble metal NPs, where the sensing is realized by monitoring the changes
in LSPR peak position arising from the refractive index alteration of the environment or
changes in nanoparticle coupling strength.255, 268 LSPR can be designed either in solution-phase
or surface-bound mode. Though solution-phase LSPR follows a simpler operation, the
colloidal stability and dilution of NPs limit their in-field application. Surface-bound LSPR (in
which NPs are immobilized on a solid surface), in contrast, alleviates the problem of NP
colloidal stability in solution and is easy to integrate into multiplex and array-based assays.
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Oligo-functionalized Au NPs are primarily used for aggregation-based DNA or RNA sensors,
where the hybridization of the target or complementary sequences cause aggregation, resulting
in the redshift of the LSPR peak.268, 269 The integration of MNPs with plasmonic NPs such as
Au, Ag, or Pt facilitates the dual benefit of MNP-based easy and various modes of conjugation,
dispersibility, and magnetic separation of preferred biomolecules, as well as plasmonic NPbased SPR signal amplification.270-272 For instance, citrate-stabilized Fe3O4@Au core-shell
NPs were employed for the multiplex detection of serum proteins and miRNAs as the plasmon
signal amplification label. Both the number of analytes bound onto the sensor (i.e., antigen for
an antibody or miRNA for a capture nucleotide) and the level of interaction of the detection
probe–loaded core/shell NP labels stimulates the SPR signal change.270 Interestingly, the
changes are larger for small oligonucleotide hybridization than for the large sandwich protein
immuno-mode. A more recent example of a magnet-assisted LSPR immunoassay in which
Fe3O4/Au core–shell NPs (FACSNPs) were utilized to fabricate sensing spots of a microarray
system.273 By coupling the unique superparamagnetic property of the iron oxide nanocore with
the strong plasmonic strength of AuNPs on the FACSNPs demonstrated superior sensitivity to
the local refractive index change upon cytokine binding. In this microarray system, a magnetassisted self-assembly was performed to obtain pattern uniform antibody functioned
microarray on a glass substrate. The FACSNP microarray can conduct 384 of tests on four
different cytokines for each sample, with 16 replicates per cytokine test. The integration of
FACSNP microarray sensors into a simple opto-fluidic device enables real-time, parallel
detection of multiple cytokines with an LOD of ≈20 pg mL-1 using 1 µL of clinical samples.
5.2.4. SERS biosensors
The surface-enhanced Raman spectroscopy (SERS) technique shows vast superiority for use in
biological systems aiding from the technology itself using Raman scattering enhancement, since it
can provide orders of magnitude of signal intensity on the employment of proper substrates and
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enhancers. Recently, SERS has been integrated with biosensing for the detection of sensitive
biomolecules such as proteins,274 DNA,275 RNA,276 and cellular components277 due to their unique
Raman responses. Generally, Au and Ag NPs are the predominantly utilized ones, as their surface
plasmons lie in the visible region of the electromagnetic spectrum that overlaps the laser excitation
wavelengths frequently used for Raman.278 The integration of MNPs has accelerated the detection
by incorporating magnetic capture of the target from clinical samples and occupying reporter
molecules (Au, Ag) or dyes. For instance, Au@MNPs, in which both plasmonic properties from Au
and magnetic properties from MNPs are integrated, thereby enhancing the SERS detection
sensitivity by increasing the active concentration of both the tag and reporter within the stationary
focus beam of a laser following magnet-based pull-down.96, 279, 280 Yang et al. explored a SERSbased immunoassay to detect an influenza virus, H3N2, through the formation of a sandwich
structure consisting of 4-mercaptobenzoic acid (4-MBA)–labeled Au NPs as SERS tags, Fe3O4/Au
NPs magnetic supporting substrates, and target influenza viruses (Fig. 17).281 In this immunosensor,
Fe3O4/Au magnetic substrates allowed for the enrichment and separation of viruses from a
biological matrix, thereby simplifying the sample pretreatment and the coupling agent 4-MBA
loaded on Au NPs bind Influenza A IgG. The 4-MBA itself acts as a Raman reporter due to its
intrinsically strong Raman scattering. The advantages of utilizing 4-MBA rely on the fact that,
unlike thioglycolic acid or α-lipoic acid, it does not require the addition of further Raman
reporter molecules.282 The developed immunoassay could detect down to H3N2 102 TCID50/mL.
Like Au, Fe3O4@Ag MNPs were utilized as both a SERS tag and a target capturing agent to
design a sensitive miRNA detection platform.279 In this sensor design, the DNA probe–
modified Fe3O4@Ag MNPs were first allowed to miRNA from cancer cells followed by DSNbased signal amplification for SERS detection. Upon the hydrolysis of the DNA probes of the
DNA/RNA duplex, the Raman tags could diffuse away from the Ag surface and induce a
Raman intensity attenuation. Though high versatility and tremendous usefulness, the precise
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fabrication of identical nanogaps distribution by means of the metal (single) is highly
challenging, which consequently limits the sensor platform from high sensitivity and
reproducibility.

Fig. 17 Schematic illustration of a magnetic SERS immunosensor for sensitive detection of avian
influenza virus. Reproduced with permission.281

The SERS platform should have both the chemical enhancement abilities and strong
electromagnetic effect to provide drastically higher sensitivity than Raman spectroscopy for
detecting trace amounts of disease-specific biomarkers (e.g., neurodegenerative disease. This
can be achieved by incorporating GO into the SERS platform, due to its ability to improve the
Raman signal through chemical enhancement.283 The unique structure of sp2-carbon
nanosheets is promising for π−π stacking, and the highly electronegative oxygen species
present on the GO surface can enhance the local electric field on the adsorbed molecules.
Additionally, GO has a strong ability to quench the molecule’s fluorescence, which adds further
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advantages as a SERS substrate via immense decreasing of the background signal. Moreover,
the platform with multiple hotspots to enrich the target analytes facilitates amplified SERS
signals. The numerous hotspots can be attained by creating subtle nanogaps using a core–shell–
satellite structure. Several researchers have reported taking advantage of both the core–shell
arrangement and the GO-induced enhancement and magnetic effect of MNPs to produce
several SERS platforms.284,
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For instance, magnetic core–plasmonic shell NP-attached

hybrid GO-based multifunctional nanoplatforms have been reported for detecting Alzheimer’s
disease (AD) biomarkers tau-protein and β-amyloid.285 In this platform, magnetic core–shell
NPs were assembled on 2D GO surface and utilized to isolate the biomarkers from complex
patient samples. However, tremendous applicability of MNPs in SERS, yet need to adopt the
integration of different functional particles and required cumbersome conjugation chemistries.
A single nanostructure with magnetic properties, high plasmonic and electronic properties, and
high analyte adsorption capabilities with an intense layer could provide a single-particle SERS
platform and overcome the existing limitation of using multiple materials and complex
chemistries.
5.3. Biosensors based on nanozymes
Peroxidases (mostly HRP) play significant roles in bioanalytical chemistry, as they are widely
used (conjugated with antibodies or signaling molecules) as signaling agents to catalyz the
oxidation of various chromogenic substances in sensor design. After Yan’s report of the
peroxidase mimetics of iron oxide NPs and their application in the development of an
immunoassay, a vast number of studies have been conducted on the design of biosensors based
on nanozymes.208, 214, 286 Yan and co-author designed two immunoassays for detecting the
hepatitis B virus surface antigen (preS1) and cardiac troponin 1 (Tn1) using ferric oxide–
immobilized protein A and an antibody, respectively. In the first immunoassay, an ELISA plate
was coated with Pres1, followed by the addition of an anti-HBV Pres1 antibody. Ferric oxide–
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immobilized protein A was then added to complete the immunorecognition events and catalyze
the TMB substrate solution to generate antigen-corresponding color signals. In the second
assay, Tn1–immobilized ferric oxide was mixed with a serum to bind the target Tn1 and
magnetically separate it from the complex serum matrix, followed by assay design onto an
ELISA plate. Based on such peroxidase mimetics, polyacrylic acid–coated iron oxide MNPs
were designed and used to detect carcinoma cells (A549 cells). The assay was able to
differentiate A549 cells from noncarcinoma cells (H9c2).287 Since then, several immunoassays
have been reported using magnetic nanoparticles. However, the nanozyme activity usually
decreases when they are modified with proteins, antibodies, or nucleotides. Recently, Yang et
al. reported that phosphate-containing adenosine analogues such as adenosine 5′monophosphate (AMP) enhance the oxidation reaction of hydrogen peroxide (H2O2) as well as
TMB oxidation.288 They have found that the nanozyme activity in Fe3O4 NPs gradually
increases with increasing AMP concentration and polyadenosine length, and it follows a trend:
AMP > adenosine 5′-diphosphate > adenosine 5′-triphosphate. Based on these AMP-enhanced
peroxidase mimetics, they have designed a selective fluorescent turnoff system for the
quantification of human serum albumin (HSA) in the urine. Very recently, we reported on
electrocatalytic and colorimetric (naked eye) detection of p53 autoantibodies using peroxidase
mimetics of gold-loaded nanoporous ferric oxide nanocubes.289 In this sensor design, the
biotinylated p53 antigen was immobilized on a neutravidin-modified screen-printed carbon
electrode (SPCE), followed by the addition of serum or plasma samples containing the target
p53 autoantibody (Fig. 18). α-Human IgG–functionalized Au−NPFe2O3NCs were then added
to the electrode surface to form an immunocomplex with the target p53 autoantibody. The
electrode surface was then covered and incubated with the freshly prepared TMB/H2O2
solution to facilitate the nanocube-catalyzed oxidation of TMB. The color change was observed
and quantified by using colorimetry and chronoamperometry.
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Fig. 18 Schematic representation of the assay for p53 autoantibody detection using the
peroxidase mimetics of gold-loaded nanoporous ferric oxide nanocubes. Reproduced with
permission.289

The peroxidase-mimicking activity of nanozymes has also been used to detect
nucleotides. For instance, a colorimetric DNA-sensing platform has been demonstrated using
dsDNA shielding activity against the peroxidase mimetics of NPs.290 The target was subjected
to PCR amplification, followed by mixing with unmodified MNPs. The PCR-amplified target
DNA present in the solution results in a decrease in access of the positively charged substrate
o-phenylenediamine (OPD) to the MNPs through its electrostatic interactions with the
negatively charged phosphate backbone of DNA and direct adsorption of DNA molecules on
the surface of MNPs. Therefore, the NPs underwent a significant inhibition of substrate OPD
and H2O2. Table 1 summarizes the recently employed (in the past three years) magnetic
nanostructures and their role in the detection of disease-specific biomarkers. In addition to the
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above-discussed strategies, other techniques, such as giant magnetoresistive (GMR),291-293
quartz crystal microbalance (QCM),294,

295

microcantilevers,296, 297 and resonance Rayleigh

scattering (RRS),298 play critical roles in the development of a sandwich assay for proteinbased biomarker detection.
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Table 1. Engineered MNPs for disease-specific biomolecular (electrochemical and optical) sensing
Magnetic nanostructures (MNSs)
Au@NPFe2O3NC
Fe3O4 NPs
CoFe2O4 MNPs
GO-loaded–iron oxide hybrid
materials
DNA–Au@MNPs as dispersible
electrodes
PdNPs@Fe-MOFs
GO-loaded MNPs
Porous Fe3O4
Fe3O4@GO@MIP
Au-coated iron oxide NPs
Fe3O4@3D–rGO@PP4VP
Au@NPFe2O3NC
Au−NPFe2O3NC
Fe3O4/TMC/Au
Fe3O4/TMC/Au

Function of MNSs
Electrochemical detection
Immobilization of miRNA
Carrying a large number of redox signaling molecules,
thionine and Fc, for target-specific DPV readout
Nanoelectrocatalyst for toluidine blue catalysis
Electrocatalytic signal enhancement
Immobilization of miRNA
DNA–Au@MNPs as dispersible electrodes
Nanocarriers for signal probe
Immobilization of redox probes and electrocatalysts for
signal enhancement
Immobilization of ssDNA
Electrocatalytic signal amplification
Immobilization of probe DNA and redox probe of
[Fe(CN)6]3–
Immobilization of target biomarker and magnetic field–
based assembly
Magnetic actuator
Immunoprobe
Aptamer immobilization
Electrode fabrication

Target biomolecule

LOD

Ref.

miRNA (miR-21)

100 fM

45

miRNA (miR-141)

0.28 fM

299

miRNA (miR-21)

0.3 fM

300

miRNA (miR-21)

100 aM

301

miRNA (miR-21)

10 aM

302

miRNA (miR-122)

0.003 fM

303

ctDNA (FGFR2 : FAM76A
fusion gene)

1 fM

304

miRNA (miR-141)

1.4 aM

305

Interleukin-8 (IL-8)

0.04 pM

306

PSA

0.085 ng/mL

307

p53 autoantibody
p53 autoantibody
Exosome

4.5 pgmL−1
29.4 pgmL−1
14 pgmL−1
0.02 U mL−1
0.08 U/mL
103 exosomes/mL

RASSF1A methylation

2×10−15 M

311

EGFR

fg/mL

312

Thrombin, PDGF-BB
LYS

Nanocarriers for target p53 from serum
Direct isolation of target protein from serum; acts as a
nanozyme
DNA probe labeled with NPS to offer an electrochemical
readout
Nanocomposite utilized as a tracing tag to label
antibodies

0

308

309
40
310

Au/MNP-CNT

ZnFe2O4/rGO
MNPs
DL–MBs
AuMNPs
SiO2-coated iron oxide NPs
Immunomagnetic beads

Iron oxide NPs
Fe3O4
MNPs
Fe3O4@SiO2–Au nanocomposites
Fe3O4
Fe3O4@Au
Iron oxide MNPs

HGNP–Fe3O4
MNPs

Magnetic alignment of sensing platform on a Pt
Influenza virus DNA
electrode
Norovirus DNA
Colorimetric and fluorescence detection
Aptamer conjugation to act as a signal probe
S. typhimurium
Immobilization of target-specific DNA probe 2
ETA gene
Immobilization of detection antibody and HRP;
EV71
colorimetric readout
Immobilization with complementary DNA probe
HPV-16 E6
Primary antibody conjugation and magnetic separation
CEA
and purification
E. coli pathogens
Carrier for purification/separation and magnetic focus
AFP
CEA
Functionalizing with detection antibody and iron oxideto-Prussian blue (PB) NP transformation for readout
PSA
signals
Recognition and concentration elements and magnetic
Aβ oligomer
separation
Functionalizing with target-specific DNA probe 1
Fluorescence quenching and magnetic separation
SPR and LSPR
Signal enhancement
Loading of capture antibody
Target delivery to the sensor surface
Binding of selective antibody
Signal enhancement due to the large refractive index and
larger mass
Capturing target IgG
Magnet-derived faster sample delivery
Signal enhancement by the combined effect of HGNPs
and Fe3O4
Capturing target CTnI and LSPR signal enhancement

1

8.4 pM
8.8 pM

313

11 CFU/mL
1.2 ng/mL

314

0.1 ng/mL

316

100 pM

317

3.7 pg/mL

318

104 CFU mL−1

319

1.0 ng mL−1

320

36 pM

321

Vibrio cholera O1 OmpW gene

2.34 ng/mL

322

PSA

3.0×10−13 g/mL

323

thrombin

0.017 nM

262

human-interleukin-17A

0.05 ngmL-1

264

MCF-7 cancer cell

500 cells/mL

324

IgG

1.88 ngmL-1

266

Cardiac troponin I (cTnI)

30 pM

325

315

Fe3O4/Au Core-shell
Fe3O4@Au core/shell
Water-dispersed MNPs
Ag@Fe3O4/rGO
Aptamer–Fe3O4 NPs

Magnet pattern sensing array and LSPR signal
enhancement

Cytokines

Target capture and immuno-recognition
3-Mode signal enhancement by the combined effect of
HGNPs, Ag, and Fe3O4
Signal amplification

273

cTnI

IL-6, 28 pM; IL-8, 18
pM; miR-21, 502 fM;
and miR-155, 483 fM
15 ngmL-1

IgG

0.019–40.00 μgmL−1

267

PrPSc

1×10–4 ng/mL

327

Interleukin (IL-6 and IL-8) &
miRNA (miR-21 and miR-155)

Signal amplification label

≈20 pgmL-1

270
326

SERS
Au-spiked silica-coated iron
oxide spheres
Fe3O4@Ag

Separation of target DNA
328
DNA oligonucleotides
Reduced signal based on hairpin structure
329
Magnetic capture, isolation, and purification of miRNA
miRNA (let-7b)
0.3 fM
Conjugation of S. aureus antibody to form sandwichStaphylococcus aureus (S.
330
Au-coated MnFe2O4
10 cells/mL
structured immunoassay
aureus)
Supporting substrates; enrichment and separation of
281
Fe3O4/Au NPs
AIV
102 TCID50/mL
viruses from a complex matrix
Iron magnetic core−gold
Target-specific antibody conjugation, magnetic
β Amyloid
0.312 ng/mL
285
plasmonic-shell NPs
separation, and electromagnetic effect on SERS hotspot
Tau protein
0.15 ng/mL
Abbreviation: TMC: N-trimethyl chitosan; EGFR: epidermal growth factor receptor; PSA: prostate-specific antigens; PrPSc: prion disease-associated isoform; AFP: alpha
fetal protein; CEA: carcinoembryonic antigen; ETA: Exotoxin A; PP4VP: plasma-polymerized 4-vinyl pyridine; EV 71: human enterovirus 71; HPV: human papillomavirus;
IgG: Immunoglobulin G; TCID50: tissue culture infection dose at 50% endpoint; AIV: avian influenza viruses.
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6. Point-of-care testing: The impact of superparamagnetic particles
With the advancement of nanotechnology, miniaturization, and microprocessors, it is now
possible to analyze samples (urine, blood, saliva, etc.) in real time while discussing with
patients. The combination of the microfluidics, paper fluidics, engineered NPs, and magnetic
impact represents the automated, integrated POC system that is relatively simple to use and
offers rapid and accurate results with moderately complex equipment. In recent decades, there
have been numerous reports on various approaches to integrating MNPs into optical,
electrochemical, and piezoelectric biosensing platforms as labels or integrating them into the
transducer.331 For instance, the use of micro-urine nanoparticles (μUNPDs) for the detection of
trace amounts of molecular markers KIM-1 and Cystatin C in urine has been reported.332 This
technique utilizes an automated on-chip assay followed by screening with a handheld device
for the readout. Currently, a lateral-flow immunoassay (LFIA) is considered to be a potent,
low-cost detection technique for biomolecules. It is highly advantageous over conventional
ELISA, as it offers one-step rapid detection by eliminating multiple additions and washing
steps.333 The commonly used detecting agents in LFIAs are gold NPs, carbon NPs, and
monodisperse latex. Though they give good detection, they lack sensitivity, as the signal
generated beneath the surface is missed by conventional optical detectors. MNPs, due to their
magnetism and brown color, can give sensitive detection that can easily be read with an optical
sensor and quantified by magnetic flow reader.334 Recently, Pt-decorated magnetic core–shell
nanoparticles (MPt/CS NPs) were demonstrated to integrate into lateral-flow POC
immunoassay strips for human chorionic gonadotropin (hCG) using the intrinsic magnetic and
enzyme-like properties of MPt/CS NPs.335 In this POC device design, MPt/CS NPs conjugated
with antibodies (Ab-MPt/CS NPs), followed by the magnetic enrichment of target analytes
using Ab-MPt/CS NPs. Ab-MPt/CS NPs capturing target analytes were then applied to the
sample pad of lateral-flow immunoassay (LFIA) strips. Ab-MPt/CS NPs containing sufficient
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amounts of target analytes were captured on the T line, whereas the remaining Ab-MPt/CS NPs
were captured on the C line. Finally, a substrate solution was applied to the test pad to obtain
amplified signals in T and C lines by peroxidase-like reactions mediated by MPt/CS NPs, as
shown in Fig. 19. A similar LFIA system has been reported for the detection of EVs isolated
from human plasma.336 In this report, different materials (colloidal gold, carbon black, and
MNPs) as LFIA labels were employed and compared. In all such MNP LFIAs, an external
magnetic field is required to magnetize the MNPs to detect them in a corresponding applied
field. Lago-Cachón et al. reported a superparamagnetic NP–based radio-frequency lateral-flow
assay (RF-LFA) method over the external magnetic field–based MLFA, where the continuous
flow of MNPs is measured.337 The main benefit of this RF-LFA system over the MNP-based
LFA is that it does not require an external magnet–based signal readout. Although the MNPbased LFA offers rapid analysis and a simplified detection system, it is not usually well suited
to multiplex analysis of several biomarkers from a particular disease or to discriminate among
multiple diseases presenting with similar symptoms.
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Fig. 19 Schematic demonstration for the detection of human hCG using magnetic nanozyme–
based LFIA strips. Reproduced with permission.335

An easy-to-use, rapid POC system that could detect multiple biomarkers
simultaneously and enable the differentiation of disease states would be highly beneficial for
in-field diagnostics of outbreaks of infectious diseases. Recently, an immunoassay technology
was reported in which the benefit of MNPs is integrated with SERS readout system to enable
the detection of three disease-specific antigens from Ebola, Lassa, and malaria from a single
blood sample.338 In this immunoassay system, disease-specific antibodies were conjugated with
both the SERS nanotags and a magnetic microparticle and stored in a tube (either liquid or
dried stage) (Fig. 20). Upon the addition of a blood sample, a sandwich was formed containing
a magnetic particle–target antigen–SERS tag followed by a magnetic pull to separate the
sandwich and bring them to the side of the reaction tube. A laser was exposed outside the tube
to illuminate the sidewall corresponding to the SERS tag in the sample. As different Raman
reporters were integrated, different SERS spectra (Fig. 20(B)), each with a unique optical
“fingerprint,” represent each nanotag (proportional to the level of antigen in the blood sample).
This POC diagnostic is highly advantageous because it does not require any washing steps, the
antibody-modified magnetic particles and SERS tags can be prepackaged, and it is highly
suitable for in-field testing. Though several POC systems integrating MNPs (either carrier,
magnetic separation, isolation, magnetic focus, or signaling label), LFAs, or an immunoassay
system and/or PCR amplification with different readouts (SERS, NMR, or colorimetry) have
been reported (Table 2), most of them require antibody functionalization, three-step sandwich
formation (using capture and detection antibodies), and a complicated readout system.339-346
Table 2 summarizes the recently reported (since 2016) magnetic nanostructure–based POC
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systems for clinics. Therefore, magnetic nanostructures that would not need any further
antibody functionalization or a complex readout strategy yet to be performed and highly
desirable for future diagnostics in clinics.

Fig. 20 Schematic representation of the detection of Ebola, Lassa, and malaria using magnetic
particles and SERS nanotags. (A) Depiction of SERS nanotag technology. (B) Characteristic
spectra from three SERS nanotags specific to the Ebola, Lassa, and malaria histidine-rich
protein 2 (HRP2) antigen. (C) Representation of the homogeneous no-wash (HNW) sandwich
immunoassay using magnetic particles and SERS nanotags. Reproduced with permission.338
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Table 2. Magnetic nanostructure–based POC diagnostic system for rapid analysis of disease biomarkers
Magnetic
nanostructure

Functions

Target biomolecule

Analyte
volume

Assay
duration

Detection limit

Ref.

Fe3O4–QD magnetic
nanosphere

Magnetic separations
Magnetic signal (readout) label

Antigens from S. typhi

1 mL

35 min

3.75×103 CFU/mL

347

MNPs

Signaling probe carrier
NMR readout

kim-1
Cystain C

-

-

0.1 ng/mL
20 ng/mL

332

MNPs

Sandwich structure formation
Magnetic support for SERS tag

Antigens from EBOV, LASV,
and malaria

45 µL

30 min

105 to
106 PFU/ml

338

Magnetic
beads

Magnet-drive fluid mixing

Hendra virus

-

15 min

0.48 ng/mL

339

Magnetic beads

Support of hybridization between capture
probe and DNA
Magnetic capture and purification

Foodborne pathogens

-

-

10 CFU/mL

340

Fe3O4 core–Au shell
nanoprobe

Magnetic capture of analyte
Magnetic focus zone

Valosin-containing proteins
(VCPs)

100 µL

1 hr 40 min

25 fg/mL

341

Sandwich structure formation

Acute myocardial infraction
(AMI)

80 µL

20 min

0.014 miu/mL

342

5 min

5 ng

343

MNPs

Fe3O4/Au/Fe3O4

Magnetic beads

Fe3O4/Sio2/QDs

Support of PCR amplification
Magnetic field–based protein
preconcentration
Magnetic focus of target
Magnetic separation of target
Fluorescent label

Genomic DNA

Troponin

100 µL

15 min

1 ng/mL

344

Clenbuterol

0.3 mL

-

0.16 ng/mL

345

0

PAA–Fe3O4
Nanocrystal clusters

Signaling label

NT–proBNP protein

70 µL

40 min

100 pg/mL

346

SMNPs

Signaling label for magnetic signals

Unconjugated estriol (µE3)

100 µL

15 min

0.86 nmol/L

348

Fe3O4/Au core–shell
nanoprobes

Modification of pathogen-specific antibodies
to control the movement of the captured
bacteria at the detection zone

E. coli O157:H7
S. typhimurium

100 μl

30 min

~23 CFU
per ml
~17 CFU
per ml

349

Au MNPs (GMNPs)

Antibody functionalization and magnetic
readout

Single nucleotide
polymorphisms (SNPs)

3 µL
genomic
DNA

5 min

0.04 pg/μL with
plasmid

350

1

7. Future perspectives and conclusion
The requirements of ultrasensitive detection of biomolecules with low concentration and
miniaturized biosensing have made the engineering of MNPs in the synthesis,
biofunctionalization, and direct application onto a sensor platform the hottest direction in
current research. As discussed in this review, many nanotechnological biosensing applications
have been reported in both academic research and commercial products over the last two
decades. Magnetism properties have been used to capture and isolate the target analytes from
a complex biomatrix, therefore reducing the presence of nonspecific biomolecules in the
sensors. The application of MNPs in biosensing has broadened when it has been capable of
functionalizing with different biomolecules through covalent and noncovalent interactions. The
biofunctional MNPs can be used as capturing agents, tracers, carriers, signal generators, signal
enhancers, catalysts, and optical emitters. The intrinsic peroxidase-mimicking properties of
MNPs have also been widely used in sensor design, and this has opened a broader window of
catalysis and replace natural enzymes. These excellent and unique physicochemical properties
make MNPs a superior choice for electronic, optical, and optoelectronic biosensor design for
the detection of cells, nucleic acid, proteins, extracellular vesicles, and pathogens. Additionally,
the nanodimension and favorable size of biomolecules may facilitate progress toward advanced
uses in point-of-care diagnostics and clinics. In this review, we have summarized recently
reported (2015 to 2019) remarkable achievements in the application of magnetic nanostructures
for the development of electrochemical and optical biosensors and POC diagnostics. Moreover,
with a brief focus on MNPs and their synthesis, biofunctionalization, and intrinsic properties
required for advanced biosensing, this review has described the challenges involved in current
MNP-based detection approaches and has offered an outlook on where imminent developments
may be focused.

0

The advances in (superpara-) magnetic, nanostructure-based, disease-specific
biomarker quantification reported in recent scientific literature are a sign of flourishing
research, though a great deal of work still needs to be performed to make it suitable for a pointof-care platform; (i) The stability of SMNPs in the aqueous system (e.g., different buffer) still
needs to be considered, as many biosensors are based on an aggregation of MNPs; (ii)
biomolecules are radially highly sensitive to environmental stress, and they require certain
physiological conditions; thus a higher degree of MNP biocompatibility is required. To
biofunctionalize them, a variety of ligands, polymers, enzymes, and inorganic materials have
been employed. Though these functionalizations enable them to be used for biosensing, the
half-life of biomolecule–MNP complexes is still low. Another restraint of such
functionalization is that the functional molecules cover the core magnetic molecules, hence
interfering with the magnetic susceptibility of MNPs. (iii) Two or more nanostructures are
generally combined to achieve functional magnetic nanostructures that have large surface
areas, are high loading, are magnetic, and have signal transduction and enhancement capacity
as well as disease-specific biomolecule binding sites. Single-step magnetic nanostructure
synthesis with in situ probe functionalization and easy signal transduction and readout
(electrochemical or optical) could also be considered for future magnetic nanostructure-based
diagnostics for clinics.
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